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Executive Summary 
 
Promoting and protecting the health of Iowans is the mission of the Iowa Department of Public Health 
(IDPH). Surveillance of notifiable health conditions is essential in establishing what, how, and when 
events impact the public’s health. Multiple divisions and bureaus are dedicated to accomplishing the 
goals of surveillance. In 2012, in addition to 850 cases reported with no lab results, there were more 
than 79,000 laboratory results of infectious diseases and conditions submitted to IDPH disease 
surveillance programs. IDPH also investigates non-infectious conditions related to lead, occupational, 
and environmental hazards like carbon monoxide. Approximately 100,000 blood lead test results were 
reported to IDPH in 2012. 
 
Crucial partners contributing to the surveillance and reduction of disease include the State Hygienic 
Laboratory (SHL) at the University of Iowa, city and county public health agencies, and health 
professionals.  
 
In 2012, the number of the vaccine-preventable diseases decreased when compared to the previous 
three-year average (2009-2011); however, the number of pertussis cases increased significantly. In 
2012, there were 1,736 cases of pertussis reported to IDPH, a 344 percent increase over the three-year 
average of 391 cases. In addition, the 2012-2013 influenza season in Iowa began earlier than usual and 
was more severe than in 2011-12 (a particularly late and mild season).  
 
Enteric diseases like salmonellosis, shigellosis, E. coli and other shiga-toxin-producing bacterial infections 
increased when compared to the previous three year average, while campylobacteriosis, giardiasis, 
cryptosporidiosis, and listeriosis decreased.  
 
Diseases spread via insects and other vectors continue to impact Iowans. In 2012, there was a notable 
number of these diseases reported to IDPH including Dengue fever, ehrlichiosis/anaplasmosis, 
hantavirus, Lyme disease, malaria, Rocky Mountain spotted fever, and West Nile virus.  Of these 
diseases detected, Lyme disease and West Nile virus had significant increases when compared to the 
previous three year average. 
 
While the number of gonorrhea diagnoses remains relatively stable, diagnoses of syphilis and chlamydial 
infections have increased. There were 120 Iowans diagnosed with human immunodeficiency virus (HIV) 
in 2012, three more cases than the average of 117 for the previous five years. The increase in HIV 
diagnoses is primarily among males, who account for 83 percent of all diagnoses since 2007. Half of all 
new HIV diagnoses occur in persons ages 25 through 44 years. However, it is important to note that 
diagnoses among persons 15 to 24 years of age have numbered 20 or more for the last four years. 
Twenty‐two persons ages 15 to 24 years were diagnosed in 2012, a slight drop of five (19%) from the 27 
diagnoses in 2011, and three times the diagnoses recorded in 2003. The data also continue to show a 
disproportionate number of diagnoses among non-Hispanic African-Americans and Hispanics. Non-
Hispanic African-Americans were about three percent of Iowa’s general population, but accounted for 
25 percent of new HIV diagnoses. While making up five percent of Iowa’s general population, Hispanics 
accounted for seven percent of new HIV diagnoses.  The number of Iowans living with HIV or AIDS (HIV 
disease prevalence) continues to increase.  As of December 31, 2012, there were 2,023 Iowans living 
with HIV or AIDS, a prevalence of 66 per 100,000 people.  This compares to 1,939 on the same date in 
2011, a prevalence of 64 per 100,000. 
 
Great strides continue to be made in improving surveillance, which has affected public health policy 
changes.  For example, childhood blood lead surveillance data continue to support the requirement for a 
child to have at least one blood lead test prior to kindergarten entry.  
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There were also 53 outbreaks reported and investigated that affected more than 800 people in 2012. 
The most common implicated pathogen was norovirus, and the typical places where the outbreaks 
occurred include restaurants, long-term care/assisted living facilities, schools, and homes.  
 
Approximately 540 Iowa Disease Surveillance System (IDSS) users reported diseases through IDSS in 
2012; a system that receives electronic laboratory results on a daily basis. Iowa’s surveillance systems 
are becoming increasingly streamlined, electronically and web-based, and interconnected. 
 
The Iowa Department of Public Health would like to take this opportunity to thank all of its partners 
including those who work at local public health agencies, clinical laboratories, hospitals, clinics, long-
term health care facilities, schools, as well as healthcare providers, infection preventionists and other 
health professionals for their continued support of disease surveillance in Iowa.   
Table 1. Summary of common notifiable diseases 2009-2012 and 
percent change in number of cases reported compared to a three-year average 
  2009 2010 2011 
3-yr average 
2009-2011 2012 
Percent 
change† 
  Number of cases ǂ    
Campylobacteriosis 552 751 747 683 534 -21.9% 
Chlamydia 9406 10542 10928 10292 11139 8.2% 
Cryptosporidiosis 232 397 364 331 328 -0.9% 
E. coli and other shiga-toxin producing  163 173 189 175 181 3.4% 
Giardiasis 291 284 271 282 251 -11.0% 
Gonorrhea 1658 1804 1966 1809 1982 9.5% 
Hepatitis A 38 11 8 19 7 -63.2% 
Hepatitis B, acute 38 15 15 23 12 -47.1% 
HIV (new diagnoses) 125 115 119 120 120 0.3% 
lead poisoning (child) 1434 1405 1244 1361 1089 -20.0% 
lead poisoning (adult) 694 736 832 754 818 8.5% 
Legionellosis 24 16 11 17 13 -23.5% 
Listeriosis 4 3 5 4 3 -25.0% 
Lyme disease 108 87 100 98 165 67.8% 
Meningococcal invasive disease 16 10 14 13 2 -85.0% 
Mumps 15 38 8 20 6 -70.5% 
Pertussis (whooping cough) 235 705 232 391 1736 344.4% 
Salmonellosis 408 530 448 462 622 34.6% 
Shigellosis 53 57 18 43 91 113.3% 
Syphilis 65 68 70 68 138 103.9% 
†The percent change is calculated by subtracting the 3-year average from the total cases for 2012 and dividing by the absolute 
value of the 3-year average.  
ǂ Table includes all confirmed and probable cases.  
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Introduction 
The purpose of this report is to provide an overall snapshot of the types and trends of notifiable and 
other diseases that occur in Iowa. When possible, details specific to the disease are provided, including 
information on which serotypes, strains or groups were prevalent and which caused outbreaks. 
Comparisons to national rates are provided whenever possible. Aggregated county-level data are 
provided in a table at the end of the report. The report is intended for use by the public, media, public 
health, and health care.  
 
The report is divided into the following sections: respiratory and vaccine-preventable diseases, sexually-
transmitted diseases, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome 
(AIDS), hepatitis C, enteric diseases, zoonotic diseases, rare and unusual diseases, and environmental 
health conditions.  
 
The Iowa Department of Public Health (IDPH) has six divisions and of those, three contributed disease 
data to this report, including Behavioral Health (BH), Acute Disease Prevention and Emergency Response 
(ADPER), and Environmental Health (EH). Two bureaus within ADPER are responsible for infectious 
disease investigation. They are the Center for Acute Disease Epidemiology (CADE) and the Bureau of 
Immunization and Tuberculosis (BIT).  
 
CADE conducts surveillance for common and emerging infectious diseases, agents of bioterrorism, 
disease outbreaks, and occurrence of rare and unusual acute diseases. BIT conducts surveillance for 
tuberculosis and perinatal hepatitis B, as well as coordinates the immunization program for the state. 
Specific disease conditions are reportable to the department per Iowa Administrative Code 641, Chapter 
1. The urgency tied to reporting varies by disease1. 
 
The Division of Environmental Health has three bureaus:  Radiological Health, Lead Poisoning Prevention 
(LPP), and Environmental Health Services (EHS). Each bureau has distinct goals and objectives and is 
comprised of very diverse programs. Certain health conditions of environmental origin are required to 
be reported to IDPH per Iowa Administrative Code 641, Chapter 1. The content in this report includes 
data from EHS, which includes disease/outbreak surveillance with the EHS‐Net program, as well as 
surveillance on carbon monoxide poisoning and methemoglobinemia. Data from the LPP include all 
reports of childhood and adult blood lead levels, reports of other heavy metal poisonings, pesticide 
poisonings, and fatal work-related injuries.  
 
The Division of Behavioral Health includes the Bureau of HIV, Sexually Transmitted Disease (STD), and 
Hepatitis. This bureau prevents, identifies, monitors, and supports persons with HIV/AIDS, STDs, and 
viral hepatitis. Disease reporting and tracking are a large component of the work accomplished by this 
bureau, as is locating, counseling, and testing partners of persons with sexually transmitted diseases.  
 
Public health emergency response planning plays a major role in preparing IDPH to respond to events of 
public health significance. Recently, the department used the incident management system in several 
events, including the severe weather in 2008 and the 2009 H1N1 pandemic. Preparedness planning at 
both the state and local levels has greatly improved the way public health responds to large-scale 
disease outbreaks.  
 
This report provides an overview of disease investigations and represents only a fraction of work 
accomplished by IDPH staff each year. The time invested in each disease report varies greatly by disease 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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and nature of the report. Some reports require a quick database query and update of an electronic file. 
Others require hours of staff time in contact tracing, mentoring and assisting other health investigators, 
and communication, education, and implementation of interventions.  
 
Support for the initiatives of the ADPER and EH divisions come from a variety of federal and state 
allocations and grants. The TB, STD, and HIV/AIDS surveillance programs are funded under separate 
cooperative agreements with the Centers for Disease Control and Prevention (CDC) and the National 
Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. 
 
Methods 
Disease reports are submitted to IDPH via phone, fax, mail, or a secure electronic reporting system. 
Reporters include health care providers, hospitals, local public health agencies, laboratories, and the 
public. CADE tracks reports of disease in Iowa residents; however acquisition or exposure to some 
illnesses may have occurred in Iowa, in another state, or outside of the United States. 
 
Reports received by CADE are tracked in the secure web-based Iowa Disease Surveillance System (IDSS). 
De-identified data are electronically exchanged between IDSS and CDC. Electronic laboratory reports are 
sent from the State Hygienic Laboratory (SHL) at the University of Iowa directly to IDPH via IDSS daily.   
 
Cases of acute infectious disease are typically referred to local public health agencies for patient 
investigations and interviews. Agencies primarily use IDSS to report information back to IDPH. Local 
public health agencies are also critical in conducting outbreak investigations. These agencies work to 
identify, investigate, and contain outbreaks at the city and county level.  
 
A few diseases require a secondary reporting system used by IDPH in transmitting data to program-
specific staff at CDC. These diseases include influenza and West Nile virus. The National Outbreak 
Reporting System (NORS) is a CDC-sponsored system used by IDPH to report outbreaks.  
 
Rates were calculated using the 2010 census population for the State of Iowa or the appropriate 
estimated census year. Five-year average values used in the graphs in the summary of enteric disease 
were calculated by adding two standard deviations to the five-year average. Calculations were 
performed with SPSS® 16, SAS® 9.3, and Microsoft® Excel. Maps were generated using ARC GIS ®.  
 
CADE uses the most recent Council of State and Territorial Epidemiologists (CSTE)/CDC case definitions 
found at www.cdc.gov/epo/dphsi/casedef/case_definitions.htm. CSTE/CDC definitions are used to 
classify each case as confirmed, probable, suspect, not a case, or awaiting more information. Only 
confirmed and probable cases meeting the CSTE/CDC definitions are included in this report.  
 
Disease case counts and Iowa-specific case demographics were retrieved from IDSS, which is maintained 
within CADE. The specific file used for this report was created in April 2012. Case reports and additional 
information received after this date that may have altered the disease counts were not included in this 
report. In addition, the data file was generated using MMWR (Morbidity Mortality Weekly Report) year 
2012. Therefore, case counts in this report may vary slightly from counts generated using the calendar 
year of 2012. 
 
Influenza surveillance data were collected from multiple sources, including outpatient health care 
providers, hospitals, public health, clinical laboratories, and schools. Laboratory-confirmed influenza 
cases were largely based on real-time polymerase chain reaction (RT-PCR) test results sent from SHL. 
Percent of outpatient visits attribute to influenza-like illness (ILI) were reported from health care 
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providers that participated in the U. S. outpatient Influenza-like Illness Surveillance Network (ILINet). 
Influenza-associated hospitalizations were reported from the sentinel hospitals that participated in the 
Iowa Influenza Surveillance Network (IISN).  
 
Respiratory syncytial virus (RSV) rapid antigen test data are used to determine the weekly positive 
predictive value of the rapid antigen tests in Iowa. SHL surveyed clinical and reference labs throughout 
the state for the number of rapid-antigen tests performed and number positive weekly and sent the 
survey results to IDPH. 
 
The surveillance case definitions for HIV, AIDS, STDs, and TB are those developed through the 
collaboration of the Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease 
Control and Prevention (CDC). Surveillance is conducted according to detailed guidelines developed by 
CDC. Several programs enter data into CDC-developed software programs. Programs transfer data via a 
secure data network on a weekly or monthly basis. HIV/AIDS data are collected in a CDC-developed 
software program called eHARS or the enhanced HIV and AIDS Reporting System. 
 
For accuracy of analysis, and because jurisdiction for HIV and AIDS cases is determined by the person’s 
residence at the time of diagnosis, great care is taken both within and between states to maintain 
unduplicated databases for HIV and AIDS. 
 
With regard to HIV/AIDS surveillance, reports are generated semi-annually, and as needed. An 
epidemiological profile is produced every three years, with annual interim updates2. HIV/AIDS data 
analysis for this report used a combination of CDC’s eHARS software, Microsoft® Excel, SAS®, and SAS® 
Enterprise Guide.  
 
In 2010, the STD program began using IDSS for surveillance of syphilis, Chlamydia, and gonorrhea. Prior 
to 2010, the STD program entered data in a CDC database called STD*MIS or the STD Management 
Information System.  
 
Environmental Heath began using IDSS in 2010 for surveillance of heavy metals, carbon monoxide, and 
methemoglobinemia. The results of blood lead testing done on all Iowa citizens are required to be 
reported to the Bureau of Lead Poisoning Prevention. Data are entered into the CDC database STELLAR. 
LPP exports data from STELLAR to CDC on a quarterly basis per programming developed by CDC. IDPH 
also analyzes STELLAR data on a quarterly basis. The analyses and reports are produced in Microsoft® 
Access and Microsoft® Excel.   
 
Most disease-specific data are transmitted to CDC electronically on a routine basis after being de-
identified. Some disease information is communicated at the request of CDC. The statistics reported by 
ADPER programs to CDC are used to develop a composite picture of disease burden in the US.  
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Summary of respiratory and vaccine-preventable diseases 
 
Haemophilus influenzae B 
Cases of Haemophilus influenzae type B (Hib), invasive disease are rare in Iowa and the US today. In 
1991, Hib vaccine was recommended for all infants after age two months. Since then, the incidence of 
Hib in children less than five years of age has declined by greater than 99 percent. There were three 
cases of Haemophilus influenzae type B reported to IDPH in 2011, but there were no cases reported in 
2012.  
 
Hepatitis A 
See Summary Enteric Disease Section. 
 
Hepatitis B (acute and chronic) 
Hepatitis B is caused by infection with the Hepatitis B virus. Hepatitis B is usually spread when blood, 
semen, or another body fluid from a person infected with the Hepatitis B virus enters the body of 
someone who is not infected. This can happen through sexual contact with an infected person or 
sharing needles, syringes, or other drug-injection equipment. Hepatitis B can also be passed from an 
infected mother to her baby at birth. 
 
Hepatitis B can be either acute or chronic. Acute hepatitis B virus infection is a short-term illness that 
occurs within the first six months after someone is exposed to the virus. Chronic hepatitis B virus 
infection is a long-term illness that occurs when the virus remains in a person’s body. Chronic hepatitis B 
is a serious disease that can result in long-term health problems and even death. 
 
A total of 12 cases or 0.4 cases for every 100,000 persons of acute hepatitis B were reported to CADE in 
2012. Sixty-seven percent of the cases were males. Nationally, acute hepatitis B infections occur 1.8 
times more often in men than in women.  
 
The Centers for Disease Control and Prevention (CDC) estimates there were 43,000 new hepatitis B 
infections in the U.S. in 2007, and between 800,000 and 1.4 million people living with chronic hepatitis B 
disease in the US. 
 
There were 227 confirmed or probable chronic hepatitis B cases reported in 2012 in Iowa. Fifty-five 
percent of the cases were females and 45 were males. 
 
Influenza  
The Iowa Influenza Surveillance Network (IISN) tracks influenza activity, age groups impacted, outbreaks, 
virus type and strain, and severity of seasonal influenza. During the 2012-2013 season, over 250 
surveillance sites reported to IISN, including medical clinics, hospitals, laboratories, schools, local public 
and health departments. IDPH analyzed the data reported from the surveillance sites and published the 
influenza weekly report during the season. To see the weekly report, visit 
www.idph.state.ia.us/IdphArchive/Archive.aspx?channel=FluReports 
 
The 2012-2013 influenza season in Iowa started earlier and was more severe than in 2011-12 (a 
particular late and mild season). The first case of seasonal influenza was confirmed by the State Hygienic 
Laboratory (SHL) in September, 2012. Influenza activity increased in November and December and 
peaked in late December, 2012 (Figure 1-3). Flu seasons typically don’t peak in Iowa until well after New 
Years. SHL identified three seasonal influenza viruses circulating in Iowa for the season - influenza A 
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(H3N2), influenza A (2009 H1N1) and influenza B. Influenza A (H3N2) viruses were predominant in Iowa, 
accounting for 76 percent of all positive influenza specimens tested. Nearly 1,000 hospitalizations were 
reported from 23 sentinel hospitals for the season and 52% of the hospitalizations were among people 
older than 64 years of age. The 2012-13 season had the highest number of hospitalizations since 
reporting began in 2006-2007. By comparison, there were only 119 hospitalizations during the mild flu 
season Iowa experienced in 2011-12.  
 
Figure 1. Laboratory-confirmed cases of influenza reported to IDPH, 2012-2013 
 
 
Figure 2. Percent of outpatient visits attribute to ILI reported from ILINet sites , 2009-2013 
 
Figure 3. Influenza-associated hospitalizations reported from sentinel hospitals, 2006-2013 
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LEGIONELLOSIS 
The average number of Legionella cases for the past three years is 17 cases. There were 13 cases of 
legionellosis reported to IDPH in 2012. More than half of the cases occurred in the eastern region of the 
state. Cases ranged from ages 24 to 73 with a median age of 56 years. All of the 13 cases were 
hospitalized and one died from the disease. 
 
Measles 
There was one confirmed case reported in 2011, but there were no cases of measles reported to IDPH in 
2012.  
 
Meningococcal invasive disease 
There were two confirmed cases of meningococcal invasive disease reported to IDPH in 2012, compared 
to 14 cases in 2011. One was 32 years old, and the other was 69 years old. Nationally, there are 0.36 
cases for every 100,000 persons.  
 
Of the two cases, one was group B and the 
other was undetermined (Table 2).  
 
 
Table 2. Cases of meningococcal disease by 
serogroups, 2012 
A B* C W135 Y Unk 
0    1 0 0 0 1 
*Serogroup B is not covered by the meningococcal vaccine
 
CDC defines a community-based outbreak of meningitis as the occurrence of three or more confirmed or 
probable cases during a period of less than or equal to three months among persons residing in the 
same area, are not close contacts of each other, and do not share a common affiliation, with a primary 
attack rate of at least 10 cases per 100,000 population3. There were no outbreaks in Iowa in 2012.  
 
Meningococcal invasive disease is fatal in 10-14 percent of cases; however, no Iowa case was fatal in 
2012. There are two types of meningococcal-vaccines currently licensed for use in the US:  1) a 
polysaccharide vaccine and 2) a conjugated vaccine. 
 
Mumps 
In 2012, there were six cases of mumps or 0.2 cases per 100,000 persons, a 71 percent decrease over 
the previous three year average of 20. Case ages in 2012 ranged from one to 54 years with a median age 
of 33 years. There were no outbreaks in Iowa in 2012. 
 
In 2006, Iowa was the center of the largest mumps outbreak in 20 years in the US with 1,963 confirmed 
and probable cases. Prior to 2006, most cases were typically imported from countries with endemic 
disease.  
 
Pertussis (Whooping cough) 
Pertussis is caused by Bordetella pertussis and before the vaccine era typically causes epidemics every 
three to five years. In 2012, there were 1,736 confirmed and probable cases reported to IDPH or 57 
cases for every 100,000 persons in Iowa, which accounts for a 344 percent increase in activity from the 
previous three-year average of 391 and had been at the highest level since 2003 (Figure 4). 
 
Seventy percent of 2012 cases occurred in children ages 0 to 14 years. Three percent of pertussis cases 
were hospitalized, and no deaths were reported.  The highest rates occurred in Fayette, Howard, Cerro 
Gordo, and Worth (Figure 5).  
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The most common symptoms are paroxysms (fits of coughing, 64%), followed by posttussive vomiting 
(29%), whooping (14%), and apnea (15%). Rare, but serious secondary conditions reported included 
pneumonia, encephalopathy, and seizures. 
 
Figure 4. Number of pertussis cases reported to IDPH by month and year, 2003-2012 
 
 
Figure 5. Pertussis rates by county, 2012 
 
 
Respiratory Syncytial Virus (RSV) 
Sentinel surveillance for respiratory syncytial virus began in 2008. IDPH and SHL solicit rapid RSV test 
results from clinical and reference labs throughout the state to determine the percentage of positive 
test results of those performed (Figure 6). In addition, various labs including SHL report polymerase 
chain reaction (PCR) or culture confirmation of RSV as a means to verify the presence of RSV in Iowa. 
The CDC considers RSV widespread in the population when the percent of rapid antigen tests that are 
positive exceeds 10 percent. During the 2012-2013 season in Iowa, this occurred in mid-November, and 
the activity peaked in early February. 
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Nationally, RSV surveillance is conducted by CDC using data from the National Respiratory and Enteric 
Virus Surveillance System. Data are reported from sentinel laboratories throughout the US on a 
voluntary basis. Recent research has highlighted variability among different regions and states in the 
US4.  
Figure 6. Percent of rapid RSV tests positive and number of tests performed, 2012-2013
 
Tuberculosis (TB) 
In 2012, Iowa reported 46 cases of active TB disease. Since 2003, Iowa averaged almost 45 cases of TB 
each year (Figure 7). Although case rates are declining, many cases have existing co-morbidities that 
make TB treatment considerably more complex and require extensive care, including the use of second 
line drugs. Treatment with second-line drugs is complicated and expensive, requiring expert 
consultation and extended treatment durations.  
 
 
 
 
Counties with larger population centers such as Polk, Woodbury, and Black Hawk report the majority of 
TB cases. However, as Figure 8 illustrates, many (52/99) Iowa counties reported TB cases during 
calendar years 2003-2012.  
 
Figure 7. Number of Iowa TB cases by year, 2002-2012 
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The 2012, TB case rate for Iowa is 1.5 cases per 100,000 persons. This is significantly lower than the 
national average of 3.2 cases per 100,000 persons. Iowa owes its low TB case rate in part to proficient 
contact investigations, health care providers’ observance of treatment guidelines, adherence to the 
Directly Observed Therapy for active disease cases, and the provision of medication for latent TB 
infections to thousands of Iowans annually. 
 
The proportion of reported TB cases in non-US-born persons has increased significantly in the past two 
decades. In 1995, for example, non-U.S. born persons accounted for 38 percent of reported TB cases 
Iowa. From 2003-2012, non-US born persons accounted for 67 percent of reported TB cases Iowa 
(Figure 9). Non-US-born persons account for only four percent of the Iowa population, highlighting the 
disparity. The decreasing numbers of US-born cases are due, in part, to effective TB control practices in 
this country.  
33%
67%
U.S. Born
Non-U.S. Born
 
 
In many parts of the developing world, TB is still widespread and remains a leading cause of death. 
Immigration of people from these countries to the United States illustrates that what happens in one 
part of the world directly impacts other parts of the world. Effective targeted testing programs for newly 
arriving refugees, immigrants, and students play a major role in identifying and treating these 
populations.  
 
Figure 9. Percent of US-born  
versus non-US-born TB cases 
in Iowa, 2002-2012 
Figure 8. Iowa counties with  
TB cases 2003-2012 
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Country of Origin Data  
For 2012, 34 individuals emigrating from 17 countries (excludes US) developed TB in Iowa. Figure 10 
represents 304 individuals, emigrating from 54 countries (excludes US) who developed TB disease after 
their arrival to Iowa 2002-2010. As the map illustrates, TB anywhere is TB everywhere. Approximately 95 
percent of all patients with active TB disease live in the developing world, where 99 percent of all TB 
deaths occur. TB is a good example of the global nature of public health. It is important to implement 
consistent and aggressive public health measures to halt TB disease, which left untreated, kills half of its 
victims. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For a detailed overview of TB, see the www.idph.state.ia.us/ImmTB/TB.aspx?prog=Tb&pg=TbHome 
Figure 10: Iowa TB cases by 
country of origin 2003-2012 
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Summary of sexually transmitted diseases, HIV and AIDS, and hepatitis C 
 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNODEFICIENCY 
SYNDROME (AIDS) 
Although there has been some year to year fluctuation, HIV diagnoses have been increasing at a rate of 
about 2.2 each year since 2000. There were 120 HIV diagnoses in 2012, an increase of 1 (0.8%) from the 
119 diagnoses reported in 2011 and also higher than the average of 117 for the previous five years.  In 
2012, as in 2011, there were 3.9 HIV diagnoses per 100,000 population, compared to 3.8 HIV diagnoses 
per 100,000 population in 2010 and 4.1 HIV diagnoses per 100,000 population in 2009. Figure 11 charts 
the number of HIV diagnoses by year for the years 2002 through 2012. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Diagnoses of HIV among the foreign-born have declined from the 10‐year high recorded in 2002 when 
32 (30%) of the 105 persons diagnosed with HIV were foreign born. By comparison, 22 (18%) of the 120 
persons diagnosed in 2012 were born in a country other than the United States (or one of its 
dependencies). 
 
While males have always accounted for the majority of HIV diagnoses, the disproportion has become 
even more pronounced since 2003.  Diagnoses among males had increased steadily, from 56 in 2003 to 
104 in 2007.  From 2008 through 2012, they have fluctuated, ranging from 82 to 105, with an average of 
96.2 per year.  Males, with 99 diagnoses, accounted for 83% of HIV diagnoses in 2012.  In contrast, 
diagnoses among females decreased from 33 in 2003 to 20 in 2007, and have averaged 19.8 per year 
since.  There were 21 females diagnosed in 2012.  Beginning in 2007, there have been about five male 
diagnoses for every one female diagnosed.  This is in contrast to three males to one female from 2003 
through 2006.   
 
The gradual increase in HIV diagnoses since 2002 is largely attributed to increases in diagnoses among 
males and, in particular, among those 15 to 24 years of age and 45 years of age and older. For the past 
four years, diagnoses among persons 15 to 24 years of age have numbered 20 or more. Twenty‐two 
persons between the ages of 15 to 24 years were diagnosed in 2012, a slight drop of 5 (19%) from the 27 
diagnoses in 2011, and three times the diagnoses recorded in 2003. While this is concerning, it is 
important not to lose sight of the fact that diagnoses among persons 25 to 44 years of age accounted for 
half of all diagnoses, with 61 (51%) persons diagnosed in 2012. The number of diagnoses among persons 
45 years and older, which had increased steadily from 18 in 2003 to a peak of 39 in 2007, then declined 
slowly to 30 in 2011 and increased again to 35 in 2012.   There were two pediatric HIV diagnoses in 
 Figure 11.  Number of Iowans diagnosed with HIV by year, 2002-2012 
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2012, children born to HIV-infected mothers.  Both children were foreign-born adoptees who had first 
been diagnosed and treated in their respective countries of birth.  Regardless of those circumstances, 
present CDC surveillance guidelines require these children to be counted as Iowa diagnoses.   
 
For persons 13 years of age and older (adults and adolescents), the median age at diagnosis in 2012 was 
38 years.  Adult/adolescent males with a median age at diagnosis of 38 years, tended to be substantially 
older than females whose median age at diagnosis was 32 years.   
 
There were 30 diagnoses in 2012 among non‐Hispanic Black persons, an increase of 6 (25%) from 24 
diagnosis in 2011, and 8 more than the five-year average of 22 from 2007 through 2011.  While 
non‐Hispanic Black persons made up almost 3 percent of Iowa’s population in 2012, they accounted for 
25 percent of the new HIV diagnoses.  This equates to 33.4 diagnoses per 100,000 non‐Hispanic Blacks 
and African-Americans. Hispanics were also overrepresented among persons diagnosed with HIV.  While 
making up five percent of Iowa’s population, Hispanics accounted for seven percent of new HIV 
diagnoses in 2012. Eight Hispanic persons were diagnosed in 2012, equating to 5.1 per 100,000 Hispanic 
persons. Despite the disparities in diagnoses among non-Hispanic Blacks and among Hispanics, the 
largest proportion of new diagnoses continued to be among non‐Hispanic White persons, who 
accounted for 63 percent of new HIV diagnoses in 2012. Seventy-five non‐Hispanic White persons were 
diagnosed in 2012, equating to 2.8 per 100,000 non-Hispanic Whites.  When the numbers of persons 
diagnosed per 100,000 population are compared, non‐Hispanic Blacks were 12 times more likely to have 
been diagnosed with HIV in 2012 than non‐Hispanic Whites.  Similarly, Hispanic persons were 1.8 times 
more likely to have been diagnosed than non‐Hispanic Whites. While non-Hispanic Asians accounted for 
three percent of HIV diagnoses in 2012, their numbers are too small to calculate a statistically reliable 
rate.  Figure 12 shows the percentage distribution of new HIV diagnoses by race and ethnicity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Men who have sex with men (MSM) remained the leading category for mode of exposure to HIV 
infection.  Diagnoses among MSM in 2012 numbered 66, consistent with the five-year average of 66 
from 2007 to 2011.  In 2012, MSM accounted for 55% of all diagnoses, consistent with the five‐year 
average of 57%.  It is important to note that 16 (80%) of the 20 diagnoses in young men between the 
ages of 15 and 24 were among MSM.   
 
Numbers (and proportions) of other modes of HIV exposure in 2012 were as follows: injection drug use 
(IDU), 7 (6%); men‐who‐have‐sex‐with-men and inject drugs (MSM/IDU), 7 (6%); heterosexual contact, 8 
(7%); and no identified risk (NIR), 30 (25%).  The seemingly high proportion of persons with unidentified 
risk is not unusual at this stage of case investigation.  By the end of 2013, risk will have been ascertained 
 
Figure 12. Percentage distribution of Iowa HIV diagnoses by race and ethnicity, 2012 
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for upwards of 85% of persons diagnosed in 2012.  As noted above, two infections were passed from 
mother to child during pregnancy or labor and delivery, but initial diagnosis and treatment of these 
infections occurred outside the U.S. prior to the adoption and immigration of the two children.  Such 
infections are termed “perinatal” or “vertical” transmission.   
 
Seventy‐two persons were diagnosed with AIDS in 2012, compared to 74 in 2011 and down from 91 (the 
highest number since 1996) in 2009.  The 72 diagnoses in 2012 are slightly less than the average of 74 
for the five years from 2007 through 2011.  Of those diagnosed with AIDS in 2012, 46 (64%) were also 
newly diagnosed with HIV and received a concurrent diagnosis of AIDS or progressed to AIDS by the end 
of 2012.  This finding is more an indication of prevention failures than it is of treatment failure or access 
to care.   
 
The number of Iowans living with HIV or AIDS continues to increase.  As of December 31, 2012, there 
were 2,023 persons living with HIV or AIDS who were Iowa residents at time of diagnosis of HIV or AIDS,  
a prevalence of 66 per 100,000 people.  This compares to 1,939 persons living with HIV/AIDS on the 
same date in 2011, a prevalence of 64 per 100,000.  Figure 13 depicts the upward trend in the estimated 
number of persons living with HIV or AIDS, as documented at the end of each calendar year.  The top 
tier of the graph represents the estimated numbers of undiagnosed/unreported persons, based on the 
surveillance program’s estimate of the completeness of case reporting and on CDC’s estimate of the 
number of persons who are infected but have not been diagnosed.  When the number of 2,023 is 
adjusted for underreporting (1%) of diagnosed HIV and AIDS and for CDC’s estimated percentage of 
undiagnosed HIV infections (20%), there may have been as many as 2,554 Iowans living with HIV or AIDS 
at the end of 2012.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hepatitis C 
Hepatitis C is the most common chronic blood-borne pathogen in the United States. According to the 
Centers for Disease Control and Prevention (CDC) there were an estimated 3.2 million people chronically 
infected with hepatitis C in the United States. According to the 2010 census population estimate for 
Iowa, there were 3,046,355 people residing in the state. CDC estimates that 1.8 percent of the state’s 
population or 54,834 Iowans have potentially been infected with the hepatitis C virus. To date, 
approximately 9,459 cases of hepatitis C have been identified by IDPH. 
 
Figure 13. Estimated number of Iowans living with HIV or AIDS as of December 31 of each 
year, 1987 through 2012. 
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Hepatitis C data are collected using IDSS, the state’s web‐based reporting system, to allow for collection 
of risk information, test results, referral information, and data on whether immunizations were offered. 
 
Sexually Transmitted Diseases 
The Bureau of HIV, STD, and Hepatitis is responsible for tracking the incidence of sexually transmitted 
diseases, including chlamydia, gonorrhea, and syphilis. In addition to disease surveillance, IDPH supports 
targeted voluntary screening at 70 public sites throughout Iowa. IDPH also works with private health 
care providers to increase screening. 
 
IDPH provides free treatment to individuals at public testing sites who test positive for chlamydia, 
gonorrhea, syphilis, or trichomoniasis. Sexual partners may be treated as well. In 2008, Iowa Code 139A 
was updated to allow for expedited partner therapy (EPT). This statute allows health care practitioners 
to give medications or prescriptions for the treatment of chlamydia or gonorrhea to their patients to 
pass along to exposed partners, particularly when the partner is unable or unwilling to come in to a 
clinic for examination. These medications may also be distributed to exposed partners via public health 
professionals. 
 
Chlamydia 
Genitourinary infections caused by Chlamydia trachomatis are extremely common in some populations. 
In fact, chlamydial infections account for the greatest number of cases of any reportable disease in the 
United States and in Iowa. Diagnoses of chlamydia have increased steadily during the past few decades. 
The reasons for this increase are varied. One important reason is that testing technology has improved, 
allowing for more sensitive tests and more convenient ways to test. The use of nucleic acid amplification 
tests (NAATs) for the detection of Chlamydia trachomatis became widespread in Iowa in the mid-2000s. 
This method of detection is much more sensitive than the previously used method of cell culture. NAATs 
also permit the use of a greater variety of specimen types. Urine and vaginal specimens (which can be 
collected much less invasively than the traditional specimen types of cervical and urethral) can be used 
for NAATs. Because most chlamydial infections cause no symptoms, there is a large pool of undiagnosed 
chlamydia in certain populations. As testing methodology has improved and as screening has increased, 
the number of cases reported has also increased.  
 
In 2012, 11,139 cases of chlamydia were reported to IDPH (Figure 14). This equates to 366 cases per 
100,000 population. Iowa is lower than the U.S. average of 426 cases per 100,000 population. Both 
nationally and in Iowa, adolescents and young adults are the most impacted populations. In Iowa, 87 
percent of reported infections occurred in persons 15 to 29 years of age. 
 
Chlamydia also disproportionately affects people of color in Iowa. Although African-Americans and other 
Black persons accounted for three percent of the population in Iowa, 17 percent of chlamydial infections 
were diagnosed in this population. In fact, according to national data from CDC6, Iowa ranks number two 
in the nation for the rate of chlamydia among the African-American/Black population in the US. 
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Figure 14. Number of cases of chlamydia and gonorrhea by year, 2000-2012 
 
Gonorrhea 
Nationally, the number of reported cases of gonorrhea has remained fairly steady over the past decade. 
However, Iowa has experienced a gradual increase in the number of reported cases in recent years. 
NAATs have been utilized for gonorrhea as they have been for chlamydia. The most widely used tests 
incorporate gonorrhea and chlamydia testing into a single specimen collection. Thus, patients are 
typically tested for both infections simultaneously.  
 
In 2012, 1,982 cases of gonorrhea were reported to IDPH (Figure 14), which equates to 65 cases per 
100,000 population. This is well below the national average of 104.2 cases per 100,000 population. 
Gonorrhea has many similarities with chlamydia, chief of which is the population (i.e., 
adolescents/young adults) that it predominately affects. Seventy-six percent of reported cases in Iowa 
were among persons 15 to 29 years of age. African-Americans/Blacks are even more disproportionately 
affected by gonorrhea than they are by chlamydia in Iowa. Thirty-seven percent of reported cases were 
among African-Americans (Figure 15). Iowa ranks number one for its rate of gonorrhea among African-
Americans in the US. 
 
Antimicrobial resistance is of continuing concern with Neisseria gonorrhoeae. The only class of 
antimicrobials still effective in the treatment of gonococcal infection is the cephalosporins. All other 
classes of antimicrobials possess insufficient efficacy to cure the infection on their own. Current 
guidelines recommend dual therapy of ceftriaxone with azithromycin or doxycycline. 7 Dual therapy is 
recommended because individuals infected with gonorrhea are often co-infected with chlamydia. 
Additionally, dual therapy may slow the development of resistance to cephalosporins. Treatment 
failures with the last remaining effective oral cephalosporin have been confirmed in North America.8 It is 
anticipated that N. gonorrhoeae will soon develop resistance to all cephalosporins, at which time 
treatment will become much more difficult. No new antimicrobials are available to treat gonorrhea. 
Researchers are investigating the use of drug combinations to cure gonococcal infections but their 
efficacies are unsubstantiated at this time. 
 
The significant disparities among African-Americans, the likelihood of further antimicrobial resistance by 
N. gonorrhoeae, and the steady number of cases make improving gonorrhea prevention a priority for 
IDPH and CDC. 
 
0
2000
4000
6000
8000
10000
12000
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
N
u
m
b
e
r 
o
f 
c
a
se
s
Year
Chlamydia Gonorrhea
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
23 
 
 
0
100
200
300
400
500
600
700
800
900
Asian Black/African
American
Hispanic American
Indian/Alaskan
Native
White Hawaiian/Pacific
Islander
R
at
e
 p
e
r 
1
0
0
,0
0
0
 p
o
p
u
la
ti
o
n
 
Syphilis 
Iowa is a low-morbidity state for syphilis; however, the number of reported cases spiked in 2012 when 
compared to previous years (Figure 16). In 2012, 138 cases of syphilis were reported to IDPH. Of these, 
81 were cases of early syphilis (primary, secondary, or early latent), which are of greatest concern to the 
public’s health because these are the infectious stages of the disease. In 2012, the rate of early syphilis 
in Iowa was 2.7 per 100,000 population. This is approximately half the U.S. average of 4.5 per 100,000 
population. The preponderance of syphilis cases occurred in men. In terms of early syphilis, 91.4 percent 
of cases were among men. Of these, the majority were men who have sex with men (MSM). Co-
infection with HIV is a concern with this population, so concurrent testing for HIV is recommended for 
persons at risk for syphilis. 
 
African-Americans/Blacks in Iowa are disproportionately affected by syphilis. Twelve percent of reported 
cases of early syphilis were among this population, equating to a rate of 11.4 cases per 100,000 
population.
Elimination of syphilis from Iowa has proven difficult due to sporadic clusters of cases and the spread 
from other states. Investigations into the increase that occurred in 2012 are ongoing. IDPH follows up on 
every case of syphilis in Iowa and ensures that partner services and treatment are offered whenever 
they are appropriate and possible.  
 
 
 
Figure 15. Gonorrhea rates in Iowa by race, 2012 
 
  Figure 16. Number of cases of syphilis by year 2000-2012 
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Summary of enteric diseases 
 
Campylobacteriosis 
The total number of campylobacteriosis cases reported in 2012 was 534. Campylobacteriosis incidence 
was 17.5 cases for every 100,000 people in 2012.  
 
Campylobacteriosis activity typically peaks in early summer. Consumption of raw, undercooked meat, 
raw milk, contaminated water, and contact with infected animals are common sources of campylobacter 
infection.  In 2012, IDPH interviewed all reported cases of Campylobacter in an attempt to identify 
clusters. One cluster related to a wedding held in eastern Iowa was identified. 
Figure 17. Campylobacteriosis cases versus 5 year average baseline by month and year, 2010-2012 
 
 
Cryptosporidiosis 
Cryptosporidiosis activity in 2012 decreased from activity in 2011. There were 13.2 cases for every 
100,000 Iowans in 2011, compared to 10.8 in 2012. Most cases reported either child care attendance or 
recreational water exposure. One outbreak was investigated that involved children swimming at a local 
pool.  
Figure 18. Cryptosporidiosis cases versus 5 year average baseline by month and year, 2010-2012 
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E. coli O157:H7 and other shiga-toxin producing strains 
The incidence of E. coli shiga-toxin cases in Iowa decreased slightly to 5.9 cases/100,000 persons in 2012 
from 6.2 cases/100,000 persons in 2011. There were 181 cases reported in 2012. In 2012, IDPH assisted 
in a national outbreak investigation involving sprouts eaten on deli sandwiches; five Iowans were 
associated with this investigation.  
Figure 19. E. coli O157:H7 and other shiga-toxin producing strains cases versus 5 year average baseline 
by month and year, 2010-2012 
 
 
Giardiasis 
Giardiasis is one of the leading waterborne diseases. It typically peaks in late summer or early fall. 
In 2012, there were 251 cases in Iowa. Diapered children and those in childcare are most likely to 
become infected with giardia. Twenty-three percent of cases were ages of five and under. There were 
8.2 cases for every 100,000 Iowans compared to 8.9/100,000 in the previous year.  
 
Figure 20. Giardiasis cases versus 5 year average baseline by month and year, 2010-2012 
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Hepatitis A 
In 2012, there were seven cases of hepatitis A reported in Iowa. This represents a 63 percent reduction 
over the previous three-year average of 19. Cases ranged from 19 to 53 years of age, with only one case 
younger than 25. Fifty-seven percent of cases were male. None of the illnesses were associated with 
outbreaks. 
Figure 21. Hepatitis A cases versus 5 year average baseline by month and year, 2010-2012 
 
 
Listeriosis 
There were three cases of Listeria monocytogenes infection reported in 2012. None were associated 
with a national outbreak.  
 
Salmonellosis 
Salmonellosis incidence in 2012 increased to 20.4 cases per 100,000 persons from 14.7 cases per 
100,000 persons in 2011. The total number of cases reported was 622. Most of these individuals were 
infected at home by handling poultry or eggs. IDPH participated in two state outbreaks; one associated 
with pork, the other with a local restaurant. One national outbreak involving cantaloupe was also 
investigated. 
Figure 22. Salmonellosis cases versus 5 year average baseline by month and year, 2010-2012 
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  Shigellosis 
In 2012, there were 91 cases of Shigella in Iowa. This was an approximately 113 percent increase over 
the average number of cases for the past three years. Approximately 38 percent of the cases were under 
5 years old; approximately 29 percent were in persons aged 24-64 years. This corresponds to children 
and their parents or caretakers being at most risk of infection.  
Figure 23. Shigellosis cases versus 5 year average baseline by month and year, 2010-2012 
 
Iowa Department of Public Health 
 28 
 
Summary of zoonotic diseases
Dengue fever 
In 2012, two cases of Dengue fever were reported to IDPH, a decrease of three from the five cases 
reported in 2011. Of the two cases, one was female and the other was male. Both were related to 
international travel to countries where the Dengue virus is endemic. 
 
Ehrlichiosis/Anaplasmosis 
There are at least three species of bacteria responsible for ehrlichiosis/anaplasmosis in the United 
States: Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Ehrlichia ewingii. The clinical signs of 
disease that result from infection with these agents are similar. 
In 2012, there were six cases of ehrlichiosis/anaplasmosis reported to IDPH, a decrease of two from the 
eight cases reported in 2011. Cases ranged from ages 43 to 79 with a median age of 59 years and were 
located in northeast part of the state. 
Hantavirus 
There was one report of hantavirus pulmonary syndrome (HPS) case in Iowa in 2012. There have been 
nine cases of HPS reported in Iowa since the disease was first identified in 1993. Substantial rodent 
exposure was identified in most cases. 
 
Lyme disease 
Lyme disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans by the bite of 
an infected tick, primarily the blacklegged tick. Symptoms of Lyme disease can include fever, headache, 
fatigue, and a “bull’s-eye” skin rash also known as erythema migrans. There were 165 cases of Lyme 
disease reported to IDPH in 2012, a 68% increase over the previous three-year average and the highest 
number of cases recorded since 2002 (Figure 24). The 2012 Iowa case rate for Lyme disease was 5.4 cases 
per 100,000 persons. Cases ranged from ages two to 86 with a median age of 44 years. 
 
Figure 24. Confirmed and probable cases of Lyme disease reported to IDPH, 2002-2012 
 
 
Malaria 
Six cases of malaria were identified in Iowa in 2012, a decrease of 16 from the 22 cases reported in 
2011. Cases ranged from ages 3 to 67 with a median age of 39 years and all patients had recently 
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immigrated to the United States. One case was determined to have Plasmodium vivax; five cases had 
Plasmodium falciparum infections. 
 
Rabies, Animal 
In 2012, 31 cases of animal rabies were reported in Iowa, which is a slight decrease from 2011 (Table 4). 
Rabies was identified most frequently in wildlife species, including 17 bats and 9 skunks. Four cases were 
diagnosed in cows and one cat also tested positive.  
 
During 2012, 1,557 animals in Iowa were tested for 
rabies and 31 were confirmed positive (1.99%). The 
percent positive varies greatly by species (Table 3). 
It is important to note that these data are greatly 
influenced by the number of animals tested. Many 
animals are tested because they have contact with 
humans or domestic animals and they exhibit 
unusual behavior or clinical signs making them more likely to be infected with the rabies virus. For these 
reasons, the percentages should not be considered representative of the true distribution of disease 
within the animal population in Iowa.  
 
There are two rabies strains that commonly circulate in Iowa - bat and skunk. Many different species can 
be infected with these strains. In animal samples that are strongly positive for rabies, SHL can 
differentiate the rabies strain that infected the animal. In 2012, SHL was able to identify the rabies strain 
in 23 of the 31 positive rabies cases. Fourteen cases were bat strain and nine were skunk strain. Bat-
strain rabies was identified in 14 bats. Skunk strain rabies was identified in eight skunks and one cat. For 
more information about rabies, visit  
www.idph.state.ia.us/Cade/DiseaseIndex.aspx?disease=Rabies. 
 
Table 4. Number of animals positive for rabies by species and by year, 2001-2012 
Species 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Bat 31 27 47 47 60 28 13 11 11 10 12 17 
Skunk 28 27 38 28 33 13 5 7 13 13 7 9 
Cat 10 7 8 11 5 7 7 9 3 1 3 1 
Cow 10 12 3 10 7 4 0 1 5 1 3 4 
Dog 2 3 6 3 2 2 5 1 2 1 0 0 
Horse 3 2 3 0 1 3 1 0 0 0 0 0 
Fox 1 0 0 1 0 0 0 0 0 1 0 0 
Squirrel 0 0 0 0 0 0 0 0 1 0 0 0 
Badger 0 0 1 0 0 0 0 0 0 0 0 0 
Total 85 78 106 100 108 57 31 29 35 27 25 31 
 
 
Rabies, Human 
Iowa’s most recent human rabies case occurred in 2002 and was caused by bat strain rabies. Prior to 
that, the last reported human case in Iowa occurred in 1951.  
  
While the exact number of people who receive rabies post-exposure prophylaxis each year in the United 
States is unknown, it is estimated to be about 40,000 people. Based upon Iowa’s population, it is 
estimated that approximately 390 Iowans receive rabies preventive treatment each year.  
Table 3. Number of animals positive for rabies 
virus by species, 2012 
Species Positive Total Tested % Positive 
Cow 4 96 4.17% 
Cat 1 361 0.28% 
Bat 17 520 3.27% 
Skunk 9 34 26.47% 
Iowa Department of Public Health 
 30 
 
Rocky Mountain Spotted Fever (RMSF) 
In 2012, there were eight cases of Rocky Mountain spotted fever (RMSF) reported in Iowa. American 
dog ticks are carriers of Rickettsia rickettsii, the bacterium that causes RMSF. The American dog tick is 
the most common species of tick in Iowa and can be found in every county in the state. The tick is most 
active late March through August. Iowa RMSF cases in 2012 had symptom onset dates from March to 
November. Cases ranged from ages four to 70, with a median age of 39. Sixty-three percent of cases 
were female. Five of the eight cases were hospitalized. 
 
West Nile Virus 
There were 31 human cases of West Nile virus reported to IDPH in 2012. Fifteen of the 31 cases were 
hospitalized, and no deaths were reported.  Cases ranged from age 8 to 88, with a median age of 52. 
Seventeen cases were male and 14 were female. The highest numbers of cases were reported in the 
northwest region of the state. For more information about this disease, visit 
www.idph.state.ia.us/CADE/DiseaseIndex.aspx?disease=West Nile Virus. 
Table 5. Iowa West Nile virus activity by species and outcome, 2002-2012 
  2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Human cases 54 147 23 37 37 30 5 5 9 9 31 
Human deaths 2 6 2 2 0 3 1 0 2 0 0 
Sentinel chickens 31 15 9 19 18 18 3 6 14 14 17 
Mosquito pools 8 27 0 7 15 5 5 9 7 5 14 
Horses 1142 96 18 15 12 10 4 3 2 1 35 
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Summary of Rare and Unusual Diseases 
 
Toxic Shock Syndrome 
There was one case of Toxic Shock Syndrome reported to IDPH in 2012, which occurred in a 16 year-old 
male.    
 
Tularemia 
There was one case of tularemia reported to IDPH in 2012, which occurred in a 45 year-old male.  
 
There were no cases of human illness reported for the following diseases: 
Hansen’s disease (Leprosy) 
Hepatitis E 
Psittacosis 
Tetanus 
Yellow Fever 
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Summary of environmental health conditions 
 
Carbon Monoxide (CO) Poisoning Surveillance 
Each year, according to the CDC, more than 400 Americans die from unintentional CO poisoning; 
additionally more than 20,000 visit the emergency room; and more than 4,000 are hospitalized due to 
CO poisoning. Fatalities are highest among Americans 65 and older. IDPH collects reports of CO 
poisoning and CO exposure from health care providers and facilities, and the Iowa Statewide Poison 
Control Center. CO poisoning is defined in Iowa as: 
 A blood carbon monoxide level equal to or greater than 10 percent carboxyhemoglobin or its 
equivalent with a breath analyzer test; or 
 A clinical diagnosis of carbon monoxide poisoning regardless of any test result.  
Information collected includes basic demographics (age, gender, county of residence), diagnosis, blood 
carboxyhemoglobin test results, exposure (circumstance, source, location), and severity of health 
impact. Reports are reviewed to identify clusters and possible occupational exposures for further  
investigation and intervention. 
 
In 2012, there was one reported death from CO 
exposure in Iowa. Fifty-nine individual reports of 
CO exposure were received by IDPH. Thirty-nine of 
these reports met the case definition for carbon 
monoxide poisoning. 
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Fatal – Patient died due to Carbon monoxide poisoning 
Moderate – Patient experienced moderate symptoms such as nausea, vomiting, confusion 
Minor – Patient experienced minor symptoms such as headache, dizziness 
No Effect – Patient experienced no symptoms consistent with CO exposure 
 
 
 
 
 
Table 6. Gender of cases with carbon monoxide 
poisoning meeting case definition, 2011 
 Number of cases 
Male 19 
Female 20 
Total 39* 
*Gender was not specified for 3 cases. 
 Figure 25. Severity of health impact among case patients with CO poisoning, 2012 
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Vehicles include automobiles and other fuel-powered recreational vehicles (e.g., boats, four-wheelers, Zamboni Ice Resurfacing machines, etc). 
Fixed appliances include fuel-burning equipment that is typically stationary (e.g., furnaces, gas water heaters, gas stoves or fireplaces). 
Mobile appliances include generators, space heaters, and other small power equipment (e.g., power washers, lawn mowers, chainsaws, etc) 
Methemoglobinemia 
Methemoglobinemia is a blood disorder caused when nitrite interacts with the hemoglobin in red blood 
cells, reducing the ability to carry sufficient oxygen to individual body cells. Infants under six months of 
age are the primary population at risk, and the condition is also known as ‘Blue Baby Syndrome.’ Sources 
of nitrite include nitrate in drinking water or from preservatives in food, some drugs, or other sources. 
 
In 2012, there was one case of methemoglobinemia reported in Iowa; it was not an infant. 
 
Heavy Metal Poisoning (Non-Lead) 
IDPH conducts surveillance for three other heavy metals in addition to lead: arsenic, cadmium, and 
mercury. Cases of poisoning from these three heavy metals are rare in Iowa, and many exposures are 
related to industrial or hobby/small market work in industries that use these metals. Outside of 
industrial use, the possibility of arsenic contamination of moonshine, herbal preparations, and 
nutritional supplements also must be considered as a source of exposure. Other potential sources of 
mercury exposure include consumption of large amounts of contaminated fish and seafood; or from 
broken thermometers, barometers, fluorescent light bulbs, or electrical switches. In 2012, there were 
two cases of mercury poisoning and arsenic, respectively, and no cases of cadmium poisoning reported. 
 
An individual walked into a bar in Armstrong, IA, on or about the night of July 20, 2012 with 
approximately 12 pounds of mercury.  The mercury was subsequently spilled in the bar. An attempt was 
made to remove the mercury using a wet-dry vacuum but the removal was only partially successful.  The 
individual who brought the mercury took the collected mercury from the vacuum and temporarily 
stored it overnight in an outdoor child's sand box at his home.  The following day,  3-4 children aged 1-7 
found the mercury, opened the container, and played with the mercury in the sand box.  A subsequent 
investigation and cleanup was completed by the U.S. Environmental Protection Agency.  Individuals 
exposed to the mercury vapor were seen by health care providers.  All exposed individuals did not 
exhibit symptoms of mercury poisoning. 
Childhood lead poisoning 
Lead has adverse effects on nearly all organ systems in the body. It is especially harmful to the 
developing brains and nervous systems of children under the age of six. At very high blood lead levels, 
Figure 26. Sources of exposure among case patients with CO poisoning, 2012  
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children can have severe brain damage or even die.  Since 1991, a child has been considered to be 
lead‐poisoned at a blood lead level of 10 μg/dL or higher.  However, recent research suggests that there 
is no level of lead exposure at which adverse health and developmental effects do not occur.  At blood 
lead levels as low as 1 microgram per deciliter (μg/dL), children’s intelligence, hearing, and growth are 
affected. This damage can be minimized if a child’s lead exposure is reduced. However, the damage 
cannot be reversed.  For the purpose of this report, a child is considered to be lead‐poisoned at a blood 
lead level of 10 μg/dL or higher.   
 
In 2002, researchers estimated that the average decrease in lifetime earnings of a child with a blood 
lead level of 10 μg/dL would be at least $40,000 and that the average decrease for a child with a blood 
lead level of 20 μg/dL would be at least $80,000.  Recent research indicates that decreases of average 
lifetime earnings also occur at much lower blood lead levels. 
 
Iowa's children are most commonly poisoned by lead‐based paint found in homes built before 1950. 
Lead‐based paint in a home becomes a lead hazard as it deteriorates and lead‐based paint chips end up 
on the floors and in window wells throughout the home, as well as in the soil around the exterior of a 
home. Since 1992, IDPH has recommended that all children under the age of six be tested for lead 
poisoning through a blood test, and the results of all blood lead testing are required to be reported to 
IDPH. State and federal laws mandate lead testing for children receiving Medicaid. Since 2008, Iowa law 
has required that all children have proof of a blood lead test when enrolling in kindergarten. 
 
IDPH reports the rate of blood lead testing among children and the prevalence of lead poisoning by birth 
cohort (a group of children born during a specific year). IDPH has complete data for children born from 
1991 through 2006. During that time period, the percentage of children tested for lead poisoning has 
increased from 26 percent to 98.6 percent.  
 
In Iowa, the prevalence of lead poisoning among children under the age of six years is 2.7 percent. At 
the national level, the prevalence of blood lead levels greater than or equal to 10 µg/dL is estimated to 
be 0.7 percent. Data collected by IDPH include the following:  the number and percentage of children 
born in 2006 who were tested for lead poisoning; the number and percentage of all children tested who 
were identified as lead‐poisoned; the number and percentage of children who were tested for lead 
poisoning and identified as lead‐poisoned by Medicaid status (see Table 15). 
 
ADULT LEAD POISONING 
A total of 5,438 blood lead test (BLL) results on 3,005 Iowans were recorded by the Iowa Adult Blood 
Lead Epidemiology and Surveillance (ABLES) program. This data includes persons 16 years or older as of 
the date of collection with a residence in Iowa tested in calendar year 2012.  All blood lead test results 
for Iowa residents are reportable to IDPH under Iowa Administrative Code 641, Chapter 1.   
 
Blood lead tests of 10 micrograms per deciliter (µg/dL) or higher are currently defined as an elevated 
blood lead level (EBL). Based on the highest BLL for each person tested in 2012, there were 818 people 
(27% of those tested) who had blood lead levels of 10 µg/dL or higher:  22 people with levels 40 µg/dL or 
higher, 174 people with levels 25-39 µg/dL, and 622 people with levels 10-24 µg/dL.   
 
Of the 818 adults with EBLs, 211 (26%) were classified as new cases; that is, they did not have a blood 
lead levels of 10 µg/dL or higher in 2010 per records in the Iowa ABLES database.  The average blood 
lead level for new cases was 19 µg/dL with a range of 10-91 µg/dL.  Of the new cases, 181 were known 
to be work-related exposures, and 165 of the work-related exposures were classified by their 
occupational industry (91% of 181).  The lead battery manufacturing industry accounted for 88 (42%) of 
the new cases.   
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Females accounted for 11.2% (92) of the 818 EBLs in 2012, with an average blood lead level of 19 µg/dL. 
The blood lead levels for EBL females ranged from 10-53 µg/dL.  Lead exposure to women during 
pregnancy poses increased health risks for unborn babies and may impact the ability to carry the 
pregnancy to term.   Women of child-bearing age (16-44 years of age i.e. those born in 1967 or later) 
accounted for 28 of the 92 female cases (30%), and 11 of the 92 EBLs females (12%) were 35 years of 
age or younger.  It is unknown if any of these women were pregnant at the time of their exposure. Most 
of the females with EBLs (81 of 92, 88%) had work-related exposure to lead, with 71 of 81 (88%) working 
in the lead battery manufacturing industry and 60 of the 92 females (65%) having an elevated blood lead 
in both 2011 and 2012.  
 
Ayurvedic product use was known as the reason for testing in 18 Iowans in 2012, with 12 EBL cases 
ranging in age from 58 to 73.  Of the 12 cases, 11 had prior EBLs in 2011 as part of a cluster of 44 EBL 
cases linked to usage of ayurvedic products obtained from India.  There was one new case in 2012 linked 
to this same source.   
 
Lead exposure due to use of firearms, making or reloading of ammunition, or making fishing jigs was 
identified in 13 Iowans in 2012.  Their EBLs ranged from 10 to 91 µg/dL, with an average of 28 µg/dL.  
 
Iowa’s high risk industries in 2012 remain consistent with data from previous years, with the majority 
(697 of 818 or 85%) of EBL adults working in manufacturing plants that use lead or metal products that 
contain lead.  The next highest industry was construction with (35 of 818 or 4%) which includes 
commercial and residential projects including painting and renovation.  Eleven employers accounted for 
700 workers with EBLs or almost 86% of the 818 Iowans with elevated blood test results for 2012.  These 
workers are also the most likely to be tested for lead exposure because of regulatory oversight or 
concerns about the risk of exposure.  Other work-related cases in 2012 include worker exposures from 
indoor firing ranges, electronic and scrap metal recycling, materials wholesalers, automotive or radiator 
repair, and leaded glass workers. Other workers may have had lead exposure but were never tested 
during the year, especially those who are self-employed or working for smaller companies.  
 
Table 7. Iowa adult blood lead test results, 2009-2012 and changes from 2011-2012 
 Number of Iowa Adults Tested  
by Highest BLL/Year 
Percent of all Iowa Adults Tested 
by BLL Range for Year 
IA ABLES DATA 2012 
Prior 3-
yr Ave 
2011 2010 2009 
2012 
change in 
numbers 
from 2011 
2012 2011 2010 2009 
BLL 40 µg/dL or higher 22 21 37 14 13 -15 0.7% 1.1% 0.5% 0.5% 
BLL 25-39 µg/dL 174 178 203 159 172 -29 5.8% 6.5% 5.5% 7.2% 
BLL 10-24 µg/dL 622 555 592 563 509 +30 20.7% 18.8% 19.4% 21.2% 
BLL 0-9 µg/dL 2187 2068 2323 2169 1711 -136 72.8% 73.6% 74.7% 71.1% 
All BLL 10+ (Total EBLS) 818 754 832 736 694 -14 27.2% 26.4% 25.3% 28.9% 
Total Individuals Tested 3005 2822 3155 2905 2405 -150     
Adults:  Persons 16 years of age or older as of date of blood test. 
Iowa Adult Data:  Test results for persons with an Iowa residential address as of date of blood test.  Blood lead test reports received without 
address data or with a residential address outside of Iowa are not included in this report.  Report reflects data in database as of May 23, 2012.  
Later data entries are not included at this time. 
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Figure 27. Number of adults by year with elevated blood lead test results, 1998-2012 
 
 
 
TRAUMATIC WORK-RELATED FATALITIES SURVEILLANCE  
The IDPH Occupational Health and Safety Surveillance Program (OHSSP) includes the Iowa Fatality 
Assessment and Control Evaluation (FACE) program, with work subcontracted to the University of Iowa 
College of Public Health Injury Prevention Research Center (UI IPRC) and collaboration with the Iowa 
Office of the State Medical Examiner. The FACE program receives funding from the National Institute of 
Occupational Safety and Health (NIOSH). 
 
Iowa FACE has identified 79 work‐related fatalities for 2012 (preliminary data), which is below the 
ten‐year average of 82.5 cases (2002-2011) and a decrease of 10 cases from 2011. Transportation 
incidents of all types are the largest single event causing work‐related fatalities in Iowa (40 of 79, 51%) 
including 23 roadway fatalities and 15 off-roadway fatalities.  Agriculturally-related (ag-related) activities 
involved 30 of the 79 deaths (38%), including 17 (43%) of the transportation incidents.  Of the 17 ag-
related transportation incidents, 9 involved tractors and 6 involved ATVs or 4-wheel utility vehicles.  
Ages for work-related traumatic fatalities ranged from 7 to 84 years of age with a median age of 54.  
Females accounted for 5% of the known work-related deaths.  Self-employed, owner operator, or family 
workers accounted for 32 of the 79 fatalities (41 %) compared to 47 fatalities where workers were 
employed or working for wages (59%).  
 
For fatalities to be included as a FACE “case”, the incident causing the work‐related death has to occur in 
Iowa (resident or non‐resident), and be traumatic in nature. Cases include work-related deaths of 
persons regardless of compensation status, that is, volunteers or family members who are working 
regardless of payment. Deaths that occur while commuting to or from work do not qualify. Iowa 
workers killed while working out of state are not included. 
 
Some potential cases may not be identified due to lack of surveillance data, especially for individuals 
killed in motor vehicle crashes when it is unknown that the person was traveling as part of their job 
duties (other than commuting). Some cases are not identified until months after the incident. Case 
definition may also vary between agencies involved in worker surveillance. For these reasons, total case 
numbers may differ between those reported by other programs, such as the US Bureau of Labor 
Statistics Census of Fatal Occupational Injuries (CFOI) or the Iowa Worker Memorial Day observance. 
Additional information can be found at www.public-health.uiowa.edu/face/.  
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*Updated data 
**Preliminary data 
Figure 28. Iowa FACE work-related death, 2001-2012    
 
* Updated data 
**Preliminary data 
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2012 Iowa summary of reported outbreak investigations  
 
Table 8. Foodborne outbreaks, 2012 
Type  Nature 
of  Episode 
Event/Place Location of 
Food 
Preparation 
Location of 
Food 
Consumption 
Region Month Number 
Affected/Number 
Exposed (if 
known) 
Food Vehicle of 
Transmission 
Agent Involved  
1.Foodborne 
 
Diarrhea, 
Vomiting, 
Fever 
Conference Caterer Conference 1 January 1 Unknown Salmonella 
Enteriditis 
 
2.Foodborne 
 
Diarrhea, 
Vomiting, 
Fever 
Restaurant Restaurant Restaurant Multi-
County 
January 5 Raw Clover 
Sprouts 
E.coli O26 
 
 
3.Foodborne 
 
Diarrhea, 
Vomiting 
Restaurant Restaurant Restaurant 2 February 4 Unknown Unknown  
4.Foodborne 
 
Diarrhea, 
Vomiting 
Restaurant Restaurant Restaurant 6 March 35/49 Unknown Norovirus   
5.Foodborne 
 
Diarrhea, 
Vomiting, 
Fever 
Baptism Home Home 3 June 29/40 Pork Salmonella 
I,4,5,12:i:- 
 
 
6.Foodborne 
 
Diarrhea, 
Vomiting 
Workplace Workplace Workplace 6 June 2 lab confirmed, 
3 epi-links 
Raw milk Campylobacter  
7. Foodborne 
 
Diarrhea, 
Abdominal 
Cramps, 
Chills 
Restaurant Restaurant Restaurant/ 
Home 
Multi-
County 
July - 
September 
23 laboratory 
confirmed 
Unknown Salmonella 
Blockley 
 
 
8. Foodborne 
 
Diarrhea, 
Abdominal 
Cramps, 
Chills 
Home Home Home Multi-
County 
July 10 laboratory 
confirmed, 1 epi-
link 
Cantaloupe Salmonella 
Typhimurium 
 
 
9. Foodborne 
 
Bloody 
Diarrhea, 
Abdominal 
Cramps, 
Nausea 
Wedding Caterer Home 6 June 1  lab confirmed, 
2 epi-links 
Unknown Campylobacter  
10. Foodborne 
 
Diarrhea, 
Abdominal 
Cramps, 
Chill 
Home Home Home Multi-
County 
May – 
August 
6 confirmed Unknown Salmonella 
Thompson 
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11. Foodborne 
 
Diarrhea, 
Vomiting, 
Fever 
Restaurant Restaurant Restaurant 6 August 1 lab confirmed Unknown E.coli O157:H7 
 
 
12. Foodborne 
 
Diarrhea, 
Abdominal 
Cramps, 
Chills 
Restaurant Restaurant Restaurant 5/Multi-
State 
August 6 lab confirmed, 
2 epi-links 
Unknown Salmonella 
I,4,5,12:i:- 
 
 
13. Foodborne 
 
Diarrhea, 
Vomiting, 
Chills 
Unknown Unknown Unknown 1 October  1 Unknown E.coli O1 
 
 
14. Foodborne 
 
Diarrhea, 
Abdominal 
Cramps, 
Chills 
Restaurant Restaurant Restaurant 6 December 1 Ground Beef Salmonella 
Typhimurium 
 
 
15. Foodborne 
 
Diarrhea, 
Vomiting, 
Chills 
Unknown Unknown Unknown 6 December 2 Unknown Salmonella 
Mbandaka 
 
 
 
Table 9. Non-foodborne or Unknown Cause Outbreaks, 2012 
Type Nature of  
Episode 
Event/Place Region Month Number 
Affected/Numbe
r Exposed (if 
known) 
Vehicle of  
Transmission 
Agent Involved, Number of  
Positive Tests, if known 
1. Person-to-
Person 
 
Diarrhea, 
Vomiting 
Birthday Party 1 January 5 Person-to-Person 
 
Norovirus - 5 
2. Person-to-
Person 
 
Diarrhea, 
Vomiting 
School-Athletes 6 January 9 Person-to-Person Norovirus - 2 
3. Person-to-
Person 
 
Diarrhea, 
Vomiting 
Restaurant 6 January 8 Person-to-Person Norovirus - 3 
4. Vaccine 
Preventable  
Vomiting, 
Fever, 
Abdominal 
Cramps 
Rehabilitation 
Facility 
4 January 15 Vaccine Preventable Influenza – AH3 
5. Person-to-
Person 
 
Diarrhea, 
Vomiting 
LTCF 6 January 3 Person-to-Person Norovirus - 2 
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6. Person-to-
Person 
 
Diarrhea, 
Vomiting 
LTCF 6 January 3 Person-to-Person Norovirus - 1 
7. Person-to-
Person 
 
Diarrhea, 
Vomiting 
College 2 January 3 Person-to-Person Suspect Norovirus 
8. Person-to-
Person 
 
Diarrhea, 
Vomiting 
LTCF 6 January 3 Person-to-Person Norovirus - 2 
9. Person-to-
Person 
 
Diarrhea, 
Vomiting 
Funeral Luncheon 3 February 5 Person-to-Person Norovirus - 4 
10. Person-to-
Person 
 
Diarrhea, 
Vomiting 
School 6 February 62 Person-to-Person Suspect Norovirus 
11. Person-to-
Person 
 
Diarrhea, 
Vomiting 
LTCF 6 February 74 Person-to-Person Suspect Norovirus 
12. Person-to-
Person 
 
Diarrhea, 
Vomiting 
Hospital 6 March 62 Person-to-Person Norovirus - 4 
13. Person-to-
Person 
 
Diarrhea, 
Vomiting 
Restaurant 4 March 13 Person-to-Person Suspect Norovirus 
14. Animal-to-
Person 
 
Diarrhea, 
Vomiting, 
Fever 
Farm Store 4 March 1 Animal-to-Person Salmonella Montevideo 
1204MOJIX-1 
15. Waterborne 
                
Nausea, 
Vomiting, 
Diarrhea 
Waterpark 6 March 75 Person-to-Person Norovirus -5 
16. Person-to-
Person 
                
Diarrhea, 
Nausea, 
Cramps 
Restaurant 6 May 10 Person-to-Person Suspect Norovirus 
17. Animal-to-
Person 
 
Diarrhea, 
Cramps 
Unknown Multi-
County 
May 2 Animal-to-Person Salmonella Infantis 
1204OHJFX-1 
18. Unknown 
 
Nausea, 
Cramps, 
Diarrhea 
Ice Cream Shoppe 6 June 8 Unknown Unknown 
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19. Person-to-
Person 
 
Nausea, 
Vomiting, 
Diarrhea 
Long-Term Care 6 August 25% of staff Unknown Norovirus - 2 
20. Person-to-
Person 
 
Nausea, 
Vomiting, 
Diarrhea 
Long-Term Care 1 August 8 Person-to-Person Norovirus -1 
21. Person-to-
Person 
 
Diarrhea, 
Vomiting 
Family Reunion 3 August 20/60 Unknown Norovirus - 2 
22. Waterborne 
 
Diarrhea, 
Cramps, 
Vomiting 
Wading Pool 1 August 6/23 Waterborne Cryptosporidium -6 
23. Person-to-
Person 
 
Diarrhea, 
Nausea, 
Vomiting 
Hospital 4 August 8/37 Person-to-Person Suspect Norovirus 
24. Person-to-
Person 
 
Bloody 
Diarrhea, 
Vomiting, 
Nausea 
Camp 1 August 4 Person-to-Person E.coli O157:H7-2 
25. Person-to-
Person 
 
Nausea, 
Vomiting, 
Diarrhea 
Rehearsal Dinner 6 September 8/270 Person-to-Person Norovirus - 3 
26. Person-to-
Person 
 
Nausea, 
Vomiting, 
Diarrhea 
Child Care 6 September 2 Person-to-Person Norovirus - 2 
27. Person-to-
Person 
 
Diarrhea, 
Cramps, 
Vomiting 
Restaurant 1 October 7 Person-to-Person Norovirus 
28. Person-to-
Person 
 
Diarrhea, 
Cramps, 
Vomiting 
School 4 October 18/145 Person-to-Person Suspect Norovirus 
29. Person-to-
Person 
 
Diarrhea, 
Nausea, 
Vomiting 
Restaurant 3 October 6 Person-to-Person Norovirus -2 
30. Person-to-
Person 
 
Vomiting Restaurant 6 October 8 Person-to-Person Suspect Toxin 
31. Person-to-
Person 
 
Nausea, 
Vomiting, 
Diarrhea 
 
Long-Term Care 2 November 27 Person-to-Person Norovirus -2 
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32. Person-to-
Person 
 
Vomiting, 
Diarrhea,  
Fever 
School 3 November 104/400 Person-to-Person Norovirus -2 
33. Person-to-
Person 
 
Vomiting, 
Diarrhea,  
 
Long-Term Care 2 December 48/109 Person-to-Person Suspect Norovirus 
34. Person-to-
Person 
 
Vomiting, 
Diarrhea 
 
Long-Term Care 3 December 16/32 Person-to-Person Suspect Norovirus 
35. Person-to-
Person 
 
Vomiting, 
Diarrhea 
Community Event 5 December 12/50 Person-to-Person Suspect Norovirus 
36. Person-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Restaurant 3 December 9/15 Person-to-Person Norovirus – 1 
37. Person-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Holiday Party 1 December 57/70 Person-to-Person Suspect Toxin 
38. Vaccine 
Preventable 
 
Fever, cough, 
sore throat  
Long-Term Care 4 December 7/38 Person-to-Person Influenza 
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Table 10. Cases and rates per 100,000 population for 2012 by age group 
 
0 to 4 5 to 19 20 to 29 30 to 39 40 to 64 >64 Unk Total 
Disease Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnoses) 1 0.5 3 0.5 13 3.2 20 5.5 34 3.4 1 0.2 0 72 2.4 
Botulism 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0 0.0 
Campylobacteriosis 57 28.2 91 14.7 91 22.1 65 18.0 162 16.2 68 15.0 0 534 17.5 
Chlamydia 3 1.5 2916 471.5 6851 1666.1 1125 310.9 241 24.1 3 0.7 0 11139 365.7 
  Cryptosporidiosis 67 33.1 74 12.0 47 11.4 39 10.8 66 6.6 35 7.7 0 328 10.8 
Dengue fever 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1 0 0.0 0 2 0.1 
E. coli/other shgt producing 44 21.8 53 8.6 35 8.5 16 4.4 24 2.4 9 2.0 0 181 5.9 
Ehrlichiosis/anaplasmosis 0 0.0 0 0.0 0 0.0 0 0.0 3 0.3 3 0.7 0 6 0.2 
Giardiasis 48 23.7 46 7.4 27 6.6 44 12.2 69 6.9 17 3.8 0 251 8.2 
Gonorrhea 1 0.5 399 64.5 1116 271.4 343 94.8 122 12.2 1 0.2 0 1982 65.1 
Hemolytic uremic syndrome 3 1.5 6 1.0 1 0.2 0 0.0 0 0.0 0 0.0 0 10 0.3 
Hepatitis A 0 0.0 1 0.2 0 0.0 1 0.3 5 0.5 0 0.0 0 7 0.2 
Hepatitis B, acute 0 0.0 0 0.0 1 0.2 4 1.1 7 0.7 0 0.0 0 12 0.4 
Hepatitis B, chronic 3 1.5 19 3.1 75 18.2 56 15.5 67 6.7 7 1.5 0 227 7.5 
HIV (diagnoses) 0 0.0 8 1.3 34 8.3 24 6.6 52 5.2 2 0.4 0 120 3.9 
Legionellosis 0 0.0 0 0.0 2 0.5 1 0.3 6 0.6 4 0.9 0 13 0.4 
Listeriosis 0 0.0 1 0.2 0 0.0 0 0.0 0 0.0 2 0.4 0 3 0.1 
Lyme disease 7 3.5 48 7.8 7 1.7 17 4.7 54 5.4 32 7.1 0 165 5.4 
Malaria 1 0.5 1 0.2 0 0.0 1 0.3 2 0.2 1 0.2 0 6 0.2 
Meningococcal Inv. Disease 0 0.0 0 0.0 0 0.0 1 0.3 0 0.0 1 0.2 0 2 0.1 
Mumps 2 1.0 0 0.0 0 0.0 2 0.6 2 0.2 0 0.0 0 6 0.2 
Pertussis (whooping cough) 260 128.6 1118 180.8 81 19.7 103 28.5 150 15.0 24 5.3 0 1736 57.0 
Q fever 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1 0 0.0 0 2 0.1 
Rocky Mountain spotted fever 1 0.5 1 0.2 0 0.0 2 0.6 3 0.3 1 0.2 0 8 0.3 
  Salmonellosis 109 53.9 98 15.8 75 18.2 68 18.8 191 19.1 81 17.9 0 622 20.4 
  Shigellosis 24 11.9 34 5.5 14 3.4 8 2.2 6 0.6 5 1.1 0 91 3.0 
Syphilis 0 0.0 5 0.8 40 9.7 30 8.3 57 5.7 6 1.3 0 138 4.5 
Tuberculosis 1 0.5 3 0.5 13 3.2 9 2.5 16 1.6 4 0.9 0 46 1.5 
Typhoid fever 0 0.0 0 0.0 2 0.5 1 0.3 0 0.0 0 0.0 0 3 0.1 
West Nile virus   0 0.0 2 0.3 0 0.0 3 0.8 16 1.6 10 2.2 0 31 1.0 
Iowa Department of Public Health 
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Table 11. Cases and rates per 100,000 population for 2012 by sex, Iowa 
  Sex 
 
Female Male Unk Total 
Disease Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnosis) 17 1.1 55 3.6 0 72 2.4 
Botulism 0 0 0  0 0 0 
Campylobacteriosis 216 14.0 316 21.0 2 534 17.5 
Chlamydia 8015 521.1 3124 207.1 0 11139 365.7 
Cryptosporidiosis 163 10.6 163 10.8 2 328 10.8 
Dengue fever 1 0.1 1 0.1 0 2 0.1 
E. coli and other shiga-toxin producing  87 5.7 93 6.2 0 180 5.9 
Ehrlichiosis/anaplasmosis  3 0.2 3 0.2 0 6 0.2 
Giardiasis 119 7.7 131 8.7 1 251 8.2 
Gonorrhea 1161 75.5 821 54.4 0 1982 65.1 
Hemolytic uremic syndrome 7 0.5 3 0.2 0 10 0.3 
Hepatitis A 3 0.2 4 0.3 0 7 0.2 
Hepatitis B, acute 4 0.3 8 0.5 0 12 0.4 
Hepatitis B, chronic 124 8.1 103 6.8 0 227 7.5 
HIV (diagnoses) 21 1.4 99 6.6 0 120 3.9 
Legionellosis 5 0.3 8 0.5 0 13 0.4 
Listeriosis 1 0.1 2 0.1 0 3 0.1 
Lyme disease 72 4.7 93 6.2 0 165 5.4 
Malaria 2 0.1 4 0.3 0 6 0.2 
Meningococcal invasive disease 0 0.0 2 0.1 0 2 0.1 
Mumps 2 0.1 4 0.3 0 6 0.2 
Pertussis (whooping cough) 882 57.3 835 55.4 19 1736 57.0 
Q fever 1 0.1 1 0.1 0 2 0.1 
Rocky Mountain spotted fever 5 0.3 3 0.2 0 8 0.3 
Salmonellosis 307 20.0 313 20.8 2 622 20.4 
Shigellosis 53 3.4 38 2.5 0 91 3.0 
Syphilis 22 1.4 116 7.7 0 138 4.5 
Tuberculosis 16 1.0 30 2.0 0 46 1.5 
Typhoid fever 1 0.1 2 0.1 0 3 0.1 
West Nile virus 14 0.9 17 1.1 0 31 1.0 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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Table 12. Notifiable diseases by year, 1992-2012 
Notifiable 
diseases 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 
 
2007 2008 2009 2010 2011 2012 
AIDS (diagnosis) 157 103 110 104 97 75 60 77 80 80 75 75 70 78 79 68 66 91 73 73 72 
Anthrax                                           
  Botulism               1         1   1 1 1 0       
  Brucellosis  1 2 1 2 4 4 1 6   2 1     1 2 0 2 2   1 0 
Campylobacteriosis 260 292 280 274 339 425 455 467 499 467 427 458 559 537 449 524 591 552 751 747 534 
Chlamydia 6125 5214 5412 5088 4165 4906 5173 5511 5989 5716 6241 6462 6958 7390 8399 8643 9372 9406 10542 10928 11139 
Cholera     1         1                           
  Cryptosporidiosis     71 21 75 71 66 56 77 82 49 122 90 122 230 610 284 232 397 364 328 
  Cyclospora         3 1 3     1               1   1 0 
  Dengue Fever                           1 1 6 5 2 2 5 2 
 Diphtheria                                           
  Ehrlichiosis                     1 1   4 7 7 7 8 2 8 6 
  Encephalitis 
(arboviral except 
WNV) 3 4 1 13 19 3 3 3 4 3 3   2   1             
E. coli/other shiga-
toxin producing 20 27 54 64 123 114 93 114 180 81 122 103 124 108 161 185 208 163 173 189 181 
Hemolytic uremic 
syndrome*                                       13 10 
  Giardiasis 351 340 339 391 410 358 429 377 420 345 315 277 301 280 302 301 326 291 284 270 251 
Gonorrhea 1653 1824 1645 1723 1144 1309 1615 1365 1394 1424 1496 1544 1249 1606 1981 1928 1700 1658 1804 1966 1982 
  Haemophilus 
influenzae Type B 7 5 6 3 4 6 5 2         1   2 1 2 1 1 3 0 
  Hansen's disease 
(Leprosy)             1   2 1       1 1   1   1     
  Hantavirus 
syndromes           2 1 2       1         1     1 1 
 Hepatitis A (viral, 
infectious) 53 58 64 106 346 490 400 161 67 41 72 40 50 22 13 48 109 38 11 8 7 
 Hepatitis B 
(serum) acute 
/chronic 33 36 27 46 74 44 54 44 38 24 20 27 17 32 21/35 269 25/226 293 15/183 15/182 12/227 
Hepatitis B 
(perinatal)                             1   1   1     
  Hepatitis C or 
unspecified 12 12 25 1 43           1 1           262 156 48 297 
Iowa Department of Public Health 
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* includes cases starting 2011
Notifiable 
diseases 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 
 
 
2007 2008 2009 2010 2011 2012 
  HIV (diagnosis)           70  73 64 92 95 105 89 105 113 108 124 101 125 115 119 120 
  Legionellosis 18 19 34 21 11 12 11 17 15 8 13 12 8 8 13 12 21 24 16 11 13 
  Listeria 
monocytogens         1   2 6 2 3 5   3 7 6 8 1 4 3 5 3 
  Lyme disease 33 8 17 16 19 8 27 24 34 36 42 58 56 91 97 124 109 108 87 100 165 
  Malaria 5 5 5 3 3 10 8 11 2 9 4 6 5 9 2 3 12 10 14 22 6 
Measles (Rubeola) 1   7   1               3         1   1 0 
  Meningococcal 
invasive disease 18 28 25 31 56 47 46 42 37 32 29 28 17 19 20 15 19 16 10 14 2 
Mumps 13 11 16 11 3 10 11 8 8 1 1 2 2 6 1,963 27 24 15 38 8 6 
Pertussis 
(whooping cough) 11 38 23 11 32 207 78 111 67 167 230 182 1066 1106 342 150 257 235 705 232 1736 
  Plague                                           
Poliomyelitis                                           
  Psittacosis 2 2               3       1               
Rabies, animal 175 78 90 141 237 160 153 159 81 83 74 105 100 108 57 31 29 35 27 25 31 
Rabies, human                     1                     
  Rocky Mountain 
spotted fever 3 7 1   1 2 2 1 2 5 7 3 2 7 5 17 8 5 5 7 8 
Rubella (German 
Measles) 3             30   1                       
  Salmonellosis 339 242 404 433 335 296 375 260 373 339 509 413 435 410 475 477 425 408 530 448 622 
  Shigellosis 46 68 338 351 151 90 69 74 569 367 122 93 64 103 134 109 214 53 57 18 91 
Syphilis 154 175 235 171 91 65 25 31 55 45 56 43 36 29 68 64 75 65 68 70 138 
Tetanus 1 1 1     1 1   1   1     1         1     
  Toxic Shock 
Syndrome 7 7 8 5 4 3 4 4 4 1 3 5 5 5     1 2 1 1 1 
  Trichinosis     1 6           3       1               
Tuberculosis 49 58 66 67 70 74 55 58 37 42 31 40 47 55 40  43 46 42 48 40 46 
Tularemia                                   1   3 1 
Typhoid fever 1       1 1   1       2       1 6   3 4 3 
  West Nile virus                     54 147 23 37 37 30 5 5 9 9 31 
  Yellow Fever                                   2       
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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Table 13. Salmonella serotypes reported, 2012 
 
 Serotype Cases   Serotype Cases 
Salmonella Agbeni 1 Salmonella Montevideo 25 
Salmonella Agona           7 Salmonella Muenchen 11 
Salmonella Altona 1 Salmonella Newport        31 
Salmonella Anatum 4 Salmonella Ohio 3 
Salmonella Baildon 1 Salmonella Oranienburg     9 
Salmonella Bareilly 1 Salmonella Oslo 1 
Salmonella Barranquilla 1 Salmonella Panama 1 
Salmonella Berta 8 Salmonella Paratyphi B  2 
Salmonella Blockley 23 Salmonella Paratyphi B var Java 4 
Salmonella Bonariensis 2 Salmonella Poona 2 
Salmonella Bovismorbificans 7 Salmonella Reading 1 
Salmonella Braenderup 9 Salmonella Saintpaul       3 
Salmonella Brandenburg 1 Salmonella Sandiego 1 
Salmonella Carrau 1 Salmonella Schwarzengrund 1 
Salmonella Corvallis 1 Salmonella Seftenberg 1 
Salmonella Derby 1 Salmonella Singapore 1 
Salmonella Enteritidis    61 Salmonella Stanley 1 
Salmonella Hadar 2 Salmonella Thompson        25 
Salmonella Hartford 13 Salmonella Typhi 3 
Salmonella Heidelberg       10 Salmonella Typhimurium 121 
Salmonella Hvittingfoss 1 Salmonella Uganda 2 
Salmonella Idikan 1 Salmonella Virchow 1 
Salmonella Infantis        15 Salmonella Worthington 2 
Salmonella Javiana      5 Salmonella Species 1 
Salmonella Johannesburg 1 Salmonella Subspecies I 92 
Iowa Department of Public Health 
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Salmonella Litchfield 1 Salmonella Subspecies IIIb 1 
Salmonella Manhattan 2   Unknown 90 
Salmonella Mbandaka         5 Total   622 
 
 
 
 
 
 
Table 14. Shigella serogroups,  1991-2012 
Shigella  
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Serogroups 
Boydii   1     1 1       4 6 2   3 1 1 0 1 1 2 1 0 
Dysenteriae 1 1       1                   1 0 0 0 0 0 0 
Flexneri 8 8 8   3 13 12 6 7 10 7 11 5 8 7 15 9 11 7 6 4 5 
Group B           3   1 1           3   2 0 0 0 0 0 
Group C       1                         2 0 0 0 0 0 
Group D   1   4 3 5   1         1       1 1 0 0 0 10 
Sonnei 24 33 50 199 119 116 62 44 55 514 306 63 62 41 58 110 97 136 45 49 10 73 
Unknown                   41 46 46 25 12 7 7 0 0 0 0 3 3 
TOTAL 
CASES 33 46 68 338 351 151 90 69 74 569 365 122 93 64 78 134 109 214 53 57 18 91 
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Table 15. Iowa children born in 2006 and tested for blood lead levels before the age of six years by county (as of 12/31/2012) 
COUNTY  2006 BIRTHS   TESTED   %TESTED   >=10μg/dL   %>=10μg/dL   COUNTY  2006 BIRTHS   TESTED   %TESTED   >=10μg/dL  %>=10μg/dL  
 Adair  97 97 100.0 4 4.1  Des Moines  557 557 100.0 30 5.4 
 Adams  64 62 96.9 6 9.7  Dickinson  173 183 105.8 0 0.0 
 Allamakee  207 228 110.1 5 2.2  Dubuque  1208 1110 91.9 11 1.0 
 Appanoose  154 138 89.6 8 5.8  Emmet  146 146 100.0 8 5.5 
 Audubon  57 57 100.0 2 3.5  Fayette  230 230 100.0 12 5.2 
 Benton  310 310 100.0 11 3.5  Floyd  220 201 91.4 2 1.0 
 Black Hawk  1776 1776 100.0 72 4.1  Franklin  124 124 100.0 12 9.7 
 Boone  329 329 100.0 11 3.3  Fremont  81 81 100.0 4 4.9 
 Bremer  297 288 97.0 9 3.1  Greene  128 128 100.0 5 3.9 
 Buchanan  340 287 84.4 5 1.7  Grundy  138 135 97.8 2 1.5 
 Buena Vista  260 260 100.0 10 3.8  Guthrie  122 122 100.0 7 5.7 
 Butler  170 170 100.0 3 1.8  Hamilton  184 184 100.0 5 2.7 
 Calhoun  108 96 88.9 3 3.1  Hancock  131 131 100.0 4 3.1 
 Carroll  302 302 100.0 10 3.3  Hardin  196 196 100.0 8 4.1 
 Cass  159 164 103.1 10 6.1  Harrison  175 163 93.1 1 0.6 
 Cedar  203 199 98.0 6 3.0  Henry  221 221 100.0 4 1.8 
 Cerro Gordo  501 501 100.0 14 2.8  Howard  127 127 100.0 3 2.4 
 Cherokee  119 119 100.0 3 2.5  Humboldt  125 125 100.0 2 1.6 
 Chickasaw  156 156 100.0 4 2.6  Ida  92 91 98.9 4 4.4 
 Clarke  126 126 100.0 7 5.6  Iowa  206 201 97.6 3 1.5 
 Clay  205 205 100.0 4 2.0  Jackson  229 229 100.0 10 4.4 
 Clayton  226 226 100.0 15 6.6  Jasper  402 402 100.0 7 1.7 
 Clinton  653 653 100.0 26 4.0 Jefferson  142 141 99.3 3 2.1 
 Crawford  249 249 100.0 7 2.8  Johnson  1615 1615 100.0 7 0.4 
 Dallas  893 893 100.0 10 1.1  Jones  212 242 114.2 6 2.5 
 Davis  138 97 70.3 1 1.0  Keokuk  139 133 95.7 7 5.3 
 Decatur  97 95 97.9 1 1.1  Kossuth  166 166 100.0 4 2.4 
 Delaware  216 196 90.7 2 1.0  Lee  454 454 100.0 20 4.4 
Iowa Department of Public Health 
 50 
 
COUNTY 2006 BIRTHS TESTED %TESTED >=10μg/dL %>=10μg/dL COUNTY 2006 BIRTHS TESTED %TESTED >=10μg/dL %>=10μg/dL 
 Linn  2869 2869 100.0 62 2.2  Poweshiek  187 159 85.0 6 3.8 
 Louisa  147 134 91.2 3 2.2  Ringgold  59 52 88.1 2 3.8 
 Lucas  125 119 95.2 0 0.0  Sac  119 119 100.0 10 8.4 
 Lyon  175 125 71.4 1 0.8  Scott  2247 2247 100.0 65 2.9 
 Madison  205 240 117.1 3 1.3  Shelby  121 131 108.3 3 2.3 
 Mahaska  322 343 106.5 11 3.2  Sioux  522 525 100.6 10 1.9 
 Marion  422 443 105.0 7 1.6  Story  999 988 98.9 10 1.0 
 Marshall  624 645 103.4 35 5.4  Tama  226 237 104.9 11 4.6 
 Mills  179 165 92.2 3 1.8  Taylor  79 74 93.7 8 10.8 
 Mitchell  119 104 87.4 2 1.9  Union  170 179 105.3 15 8.4 
 Monona  120 132 110.0 6 4.5  Van Buren  89 69 77.5 2 2.9 
 Monroe  96 104 108.3 2 1.9  Wapello  496 496 100.0 22 4.4 
 Montgomery  137 145 105.8 4 2.8  Warren  515 503 97.7 5 1.0 
 Muscatine  633 814 128.6 18 2.2  Washington  316 280 88.6 8 2.9 
 O'Brien  170 169 99.4 6 3.6  Wayne  88 85 96.6 4 4.7 
 Osceola  70 73 104.3 2 2.7  Webster  485 485 100.0 16 3.3 
 Page  177 169 95.5 9 5.3  Winnebago  142 142 100.0 0 0.0 
 Palo Alto  126 112 88.9 0 0.0  Winneshiek  190 190 100.0 8 4.2 
 Plymouth  306 328 107.2 7 2.1  Woodbury  1697 1697 100.0 100 5.9 
 Pocahontas  68 71 104.4 3 4.2  Worth  86 86 100.0 2 2.3 
 Polk  6911 6915 100.1 114 1.6  Wright  176 176 100.0 8 4.5 
 Pottawattamie  1227 884 72.0 16 1.8  TOTALS  40592 40043 98.6 1089 2.7 
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Table 16. 2012 Iowa adult blood testing summary by county 
COUNTY # tested # BLL result > 10 µg/dL COUNTY # tested  # BLL result > 10 µg/dL COUNTY   # tested # BLL result > 10 µg/dL 
Adair  <5 0 Floyd  <5 0 Monona 6 <5 
Adams 6 <5 Franklin 14 <5 Monroe 14 7 
Allamakee 5 0 Fremont 13 5 Montgomery 45 26 
Appanoose 46 32 Greene <5 0 Muscatine 55 <5 
Audubon 10 5 Grundy 8 <5 O’Brien <5 0 
Benton 15 <5 Guthrie 5 0 Osceola <5 0 
Black Hawk  83 6 Hamilton 11 0 Page 26 9 
Boone  14 0 Hancock <5 0 Palo Alto 9 0 
Bremer  19 0 Hardin 9 0 Plymouth 6 0 
Buchanan  79 36 Harrison <5 0 Pocahontas <5 <5 
Buena Vista 13 <5 Henry 15 0 Polk 248 9 
Butler 8 0 Howard 7 <5 Pottawattamie 37 <5 
Calhoun 6 0 Humboldt 5 0 Poweshiek 8 <5 
Carroll 14 <5 Ida <5 0 Ringgold <5 0 
Cass  32 14 Iowa 9 0 Sac 7 0 
Cedar 22 <5 Jackson 23 7 Scott  235 17 
Cerro Gordo 22 0 Jasper 9 0 Shelby 7 <5 
Cherokee 0 0 Jefferson 57 19 Sioux 5 0 
Chickasaw  8 0 Johnson 110 <5 Story 52 <5 
Clarke 7 <5 Jones 21 5 Tama 8 0 
Clay 6 0 Keokuk 21 5 Taylor 9 0 
Clayton 67 50 Kossuth 6 0 Union <5 0 
Clinton 59 <5 Lee 41 <5 Van Buren 11 <5 
Crawford 5 <5 Linn 205 22 Wapello 35 10 
Dallas 20 0 Louisa 7 0 Warren 25 <5 
Davis 7 <5 Lucas 40 23 Washington 14 0 
Decatur 9 6 Lyon 5 0 Wayne 118 94 
Delaware 252 217 Madison 7 0 Webster 22 <5 
Des Moines 38 <5 Mahaska 40 12 Winnebago <5 0 
Dickinson 12 <5 Marion 18 <5 Winneshiek 12 <5 
Dubuque 206 106 Marshall 19 <5 Woodbury 63 6 
Emmet <5 0 Mills 15 <5 Worth 6 0 
Fayette  39 10 Mitchell 6 0 Wright
 
12 0 
Based on highest test result in 2012 per adult (16 yo at time of test) residing in Iowa. Numbers 1-4 are suppressed and shown as <5. An elevated blood lead level 
(EBL) is considered a venous result greater than or equal to 10 micrograms per deciliter (µg/dL). Total including suppressed data
 
 
3005 
 
818 
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Table 17. Common notifiable diseases by county, 2012 
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ADAIR 0 0 3 5  1 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 2 0 0 0 0 
ADAMS 0 0 0 10  1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 
ALLAMAKEE 0 0 11 20  3 3 1 3 0 0 0 0 2 0 0 11 0 0 24 0 0 2 0 0 0 0 
APPANOOSE 0 0 1 23  0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
AUDUBON 0 0 1 21  0 1 0 0 2 1 0 0 0 0 0 0 0 0 0 1 0 2 0 1 0 0 
BENTON 0 5 8 52  5 3 1 2 1 0 0 0 0 0 0 0 0 0 39 0 0 5 0 0 0 0 
BLACK HAWK 0 * 11 868  0 3 0 4 181 0 1 0 16 3 0 5 0 0 16 0 1 28 0 4 4 0 
BOONE 0 * 3 60  1 0 0 3 8 0 0 0 1 0 0 3 0 0 3 1 0 5 0 1 0 1 
BREMER 0 0 4 46  0 0 0 4 8 0 0 0 0 0 0 1 0 0 15 0 0 5 1 1 0 0 
BUCHANAN 0 0 8 46  1 7 0 2 3 2 0 0 1 1 0 1 0 0 14 0 0 2 0 0 0 0 
BUENA VISTA 0 * 5 56  2 0 0 1 2 0 0 0 4 0 0 0 0 0 12 0 0 6 0 1 2 0 
BUTLER 0 0 3 31  0 1 0 1 0 0 0 0 0 0 0 0 0 0 5 0 0 2 0 1 0 0 
CALHOUN 0 0 0 18  6 0 0 2 1 0 0 0 2 1 0 0 0 0 1 0 0 2 0 0 0 0 
CARROLL * * 1 42  5 5 0 4 5 0 0 0 1 0 0 0 0 0 10 0 0 3 0 0 0 0 
CASS 0 0 2 41  0 4 0 0 2 0 0 1 0 0 0 0 0 0 3 1 0 1 0 0 0 1 
CEDAR 0 0 7 41  0 1 1 0 6 0 0 0 0 0 0 0 0 0 5 0 1 7 0 0 0 0 
CERRO GORDO * * 8 90 0 0 0 4 6 0 0 0 1 0 0 0 0 0 159 1 0 8 0 0 0 0 
CHEROKEE 0 0 0 15  0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 5 0 0 0 1 
CHICKASAW 0 0 0 14  3 0 0 0 0 0 0 0 2 0 0 2 0 0 3 0 0 4 0 0 0 0 
CLARKE 0 0 2 29  0 6 0 1 2 0 0 0 0 0 0 0 0 0 3 0 0 9 0 1 0 0 
CLAY 0 0 3 39  4 1 0 4 0 0 0 0 0 1 0 0 0 0 1 1 0 2 3 1 0 0 
CLAYTON * 0 9 19  3 2 2 3 0 0 0 0 1 0 0 12 0 0 5 0 0 1 0 0 0 0 
CLINTON * * 7 175  1 4 0 1 31 0 0 0 3 0 0 3 0 0 8 1 1 7 0 0 0 0 
CRAWFORD 0 0 2 64  2 0 0 2 1 0 0 0 1 0 0 0 0 0 2 0 0 2 0 0 0 0 
DALLAS * * 6 135  9 2 0 7 26 0 0 0 7 0 0 1 0 0 9 1 1 14 4 2 1 0 
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DAVIS 0 0 0 21 2 4 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 0 0 0 
DECATUR * 0 2 28 1 0 0 1 6 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 
DELAWARE 0 0 7 25 1 3 0 0 2 0 0 0 0 0 0 2 0 0 24 0 0 6 0 1 0 0 
DES MOINES * 0 7 179 4 1 0 4 27 1 0 0 3 0 0 0 0 0 8 0 0 3 1 0 0 1 
DICKINSON 0 0 3 22 3 0 0 1 3 0 0 0 1 0 1 0 0 0 0 1 0 0 2 0 0 2 
DUBUQUE * 6 29 376 29 7 0 9 55 0 0 1 1 1 0 9 0 0 76 1 0 12 1 3 1 0 
EMMET 0 0 0 37 1 1 0 0 1 0 0 0 2 0 0 0 0 0 0 1 0 2 0 0 0 0 
FAYETTE 0 0 8 35 2 1 0 0 7 0 0 1 0 1 0 4 0 0 79 0 1 5 0 0 0 0 
FLOYD 0 0 3 39 7 3 0 1 1 0 0 0 1 0 0 1 0 0 12 0 0 2 0 0 0 1 
FRANKLIN 0 0 6 29 0 0 0 1 1 0 0 0 0 0 0 0 0 0 19 0 0 4 0 1 0 0 
FREMONT 0 0 4 12 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 1 
GREENE 0 0 2 33 1 0 0 0 5 0 3 0 1 1 0 0 0 0 3 0 0 0 0 0 0 0 
GRUNDY 0 0 1 25 0 0 0 0 2 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 1 
GUTHRIE * * 4 17 1 0 0 1 4 0 0 0 1 0 0 0 0 0 1 1 0 1 0 0 0 0 
HAMILTON 0 0 6 53 0 0 0 1 2 0 0 0 1 0 0 1 0 1 0 0 0 5 0 0 2 0 
HANCOCK 0 0 1 5 0 0 0 2 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 0 0 
HARDIN 0 0 3 32 0 0 0 0 1 0 0 0 0 0 0 1 0 0 5 0 0 4 0 0 0 0 
HARRISON 0 0 2 31 1 1 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 
HENRY 0 0 3 75 1 1 0 2 4 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 
HOWARD 0 0 1 11 2 0 0 1 0 0 0 0 0 0 0 0 0 0 36 0 0 6 0 0 0 0 
HUMBOLDT 0 0 1 21 2 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 
IDA 0 0 1 13 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 
IOWA 0 0 3 31 0 2 0 0 1 0 0 0 0 0 0 1 0 0 13 0 0 5 0 0 0 0 
JACKSON * * 17 52 14 2 0 0 2 0 0 0 1 0 0 3 0 0 2 0 0 9 0 0 0 0 
JASPER * * 3 108 14 5 0 2 9 0 0 0 0 0 0 1 0 0 4 0 0 5 0 0 0 0 
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JEFFERSON 0 0 1 27 5 1 0 6 0 0 0 0 0 0 0 1 1 0 0 0 0 2 0 0 1 0 
JOHNSON 8 17 26 701 9 16 1 7 109 2 0 2 15 1 0 26 0 1 136 0 0 23 2 14 4 0 
JONES 0 0 11 37 8 1 0 4 6 0 0 0 0 0 0 1 0 0 3 0 0 7 0 1 0 0 
KEOKUK 0 0 2 25 2 2 0 1 3 0 0 0 0 0 0 1 0 0 0 0 0 3 0 0 0 0 
KOSSUTH 0 0 1 18 0 1 0 0 0 0 0 0 0 1 0 0 0 0 3 1 0 2 0 0 0 0 
LEE * * 5 155 1 1 0 0 8 0 0 0 0 0 0 1 0 0 1 0 0 18 0 0 0 0 
LINN 8 13 45 986 16 10 0 24 230 0 0 0 17 1 1 13 0 1 288 0 0 29 2 7 4 1 
LOUISA 0 * 2 37 1 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 0 0 0 0 2 0 
LUCAS 0 0 5 21 0 1 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 2 0 0 
LYON 0 0 9 11 4 3 0 5 0 0 0 0 0 0 0 0 0 1 0 0 0 4 0 0 0 3 
MADISON * * 1 27 1 2 0 0 4 0 0 0 0 0 0 0 0 0 4 0 0 3 0 0 0 1 
MAHASKA 0 0 0 61 0 2 0 1 11 1 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 
MARION * * 3 75 4 2 0 0 9 0 0 0 0 0 0 4 0 0 3 0 0 11 0 0 0 1 
MARSHALL * * 10 196 0 0 0 3 11 0 0 0 8 0 0 2 0 0 5 2 0 7 0 0 1 0 
MILLS 0 * 0 25 1 0 0 1 1 0 0 0 2 0 0 0 0 0 6 1 0 5 0 0 0 0 
MITCHELL 0 0 5 7 2 0 0 0 0 0 0 0 0 0 0 1 0 0 4 3 0 2 0 0 0 0 
MONONA 0 0 3 16 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
MONROE 0 0 1 18 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 
MONTGOMERY * * 3 25 0 1 0 0 1 0 0 0 0 0 0 1 0 0 2 0 0 4 0 0 1 1 
MUSCATINE 0 0 5 148 2 1 0 2 20 0 0 1 3 0 0 7 0 0 10 0 0 8 0 1 1 0 
O'BRIEN 0 0 9 18 1 1 0 3 2 0 0 0 1 0 0 0 0 0 0 0 0 3 0 2 0 0 
OSCEOLA 0 0 2 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 1 0 0 0 
PAGE 0 0 2 60 2 0 0 0 5 0 0 0 1 0 0 0 0 0 1 0 0 3 0 0 0 2 
PALO ALTO 0 0 0 9 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 3 2 0 0 1 
PLYMOUTH 0 0 4 66 15 0 0 4 1 0 0 0 0 0 0 0 0 0 10 0 0 11 0 0 1 2 
POCAHONTAS * * 3 9 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 
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POLK 21 37 35 2,035 29 16 0 48 593 2 2 1 65 1 0 10 0 1 172 2 0 89 36 61 12 1 
POTTAWATTAMIE * * 7 387 10 3 0 6 92 0 0 1 3 0 0 0 0 0 49 0 1 23 32 1 0 2 
POWESHIEK 0 0 2 76 3 0 0 0 3 0 0 0 0 0 0 1 0 0 1 0 0 2 0 0 0 0 
RINGGOLD 0 0 0 6 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
SAC 0 0 8 10 2 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 7 0 0 0 0 
SCOTT 4 9 28 932 10 11 0 9 271 1 0 1 13 0 0 11 1 0 171 0 0 22 0 8 0 0 
SHELBY * 0 0 15 3 1 0 1 4 0 0 0 1 0 0 0 0 0 4 0 0 5 0 0 0 0 
SIOUX 0 0 11 45 13 11 0 10 4 0 0 0 3 0 0 1 0 0 0 3 0 16 0 1 0 1 
STORY * * 13 321 1 5 0 7 32 0 0 0 21 0 0 2 0 1 70 2 0 22 0 10 3 0 
TAMA 0 0 3 63 0 0 0 3 2 0 0 0 0 0 0 0 0 0 2 0 0 4 0 0 0 2 
TAYLOR 0 0 0 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
UNION 0 0 0 43 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
VAN BUREN 0 0 1 11 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
WAPELLO * * 7 169 16 0 0 6 17 0 0 1 2 0 0 2 0 0 3 1 0 14 2 1 3 0 
WARREN 0 0 2 91 4 1 0 2 12 0 0 1 1 0 0 0 0 0 22 0 0 9 0 1 0 0 
WASHINGTON * 0 2 55 1 4 0 0 10 0 0 0 0 0 0 1 0 0 3 0 0 5 0 0 0 0 
WAYNE 0 0 1 11 0 0 0 0 0 0 0 1 0 0 0 0 0 0 12 0 0 0 0 0 0 0 
WEBSTER * * 2 163 2 1 0 4 35 0 0 0 3 0 0 2 0 0 4 1 0 4 0 1 1 0 
WINNEBAGO 0 0 1 20 0 0 0 0 0 0 0 0 0 0 0 1 0 0 6 0 0 0 0 0 0 0 
WINNESHIEK 0 * 9 24 2 0 0 4 0 0 0 0 0 0 0 8 0 0 29 0 0 6 0 1 1 0 
WOODBURY * * 14 559 15 3 0 10 58 0 0 0 10 0 0 0 0 0 48 1 0 27 0 6 1 3 
WORTH 0 0 2 8 0 0 0 0 2 0 0 0 0 0 0 0 0 0 26 0 0 1 0 0 0 0 
WRIGHT 0 0 6 25 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 2 0 1 0 0 
Total 72 120 534 11139 328 181 6 251 1982 10 7 12 227 13 3 165 2 6 1736 31 8 622 91 138 46 31 
*in the ‘HIV (diagnoses)’ column indicates only 1-3 HIV diagnoses reported for that county 
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